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1. INTRODUCTION
1.1 TUMOR1:
Neoplasia  literally  means  the  process  of  "new  growth,"  and  a  new  growth  is  called  a
neoplasm. The term tumor was originally applied to the swelling caused by inflammation.
Neoplasms also may induce swellings,  but  by long precedent,  the non-euplastic usage of
tumor has passed into limbo; thus, the term is now equated with neoplasm. Oncology (Greek
oncos = tumor) is the study of tumors or neoplasm’s. Cancer is the common term for all
malignant  tumors.  Although  the  ancient  origins  of  this  term  are  somewhat  uncertain,  it
probably derives from the Latin for crab, cancer-presumably because a cancer "adheres to
any part that it seizes upon in an obstinate manner like the crab." Although all physicians
know what they mean when they use the term neoplasm, it has been surprisingly difficult to
develop an accurate definition. The eminent British Oncologist Willis has come closest: "A
neoplasm is an abnormal mass of tissue, the growth of which exceeds and is uncoordinated
with that of the normal tissues and persists in the same excessive manner after cessation of
the stimuli which evoked the change." We know that the persistence of tumors, even after the
inciting stimulus is gone, results from heritable genetic alterations that are passed down to
the  progeny  of  the  tumor  cells.  These  genetic  changes  allow excessive  and  unregulated
proliferation  that  becomes  autonomous  (independent  of  physiologic  growth  stimuli),
although tumors generally remain dependent on the host for their nutrition and blood supply.
As we shall discuss later, the entire population of cells within a tumor arises from a single
cell that has incurred genetic change, and hence tumors are said to be clonal.
1.2 Nomenclature:
All  tumors,  benign  and  malignant,  have  two  basic  components:  (1)  proliferating
neoplastic  cells  that  constitute  their  parenchyma  and  (2)  supportive  stroma  made  up  of
connective tissue and blood vessels. Although parenchymal cells represent the proliferating
"cutting edge" of neoplasm’s and so determine their behavior and pathologic consequences,
the growth and evolution of neoplasm’s are critically dependent on their stroma. An adequate
stromal blood supply is requisite, and the stromal connective tissue provides the framework
for the parenchyma. In addition, there is cross-talk between tumor cells and stromal cells that
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appears to directly influence the growth of tumors. In some tumors, the stromal support is
scant and so the neoplasm is soft and fleshy. Sometimes the parenchymal cells stimulate the
formation of an abundant collagenous stroma, referred to as desmoplasia. 
1.3 DEFINITION:
Solid tumors are defined as abnormal masses of tissue that usually do not contain
cysts  or  liquid  areas.  Solid  tumors  may  be  benign  (not  cancerous),  or  malignant
(cancerous). A number of malignant diseases are often also categorized as “solid tumors”
in the clinic such as breast cancer, cancer of the pancreas, lung, colon, etc.
 Solid tumors can be split into three separate categories, depending on the type of
cells from which they typically arise in the patient’s body, which include:
• Sarcomas: Cancers arising from connective or supporting tissues such as bone or
muscle.
• Carcinomas: Cancers arising from the body's glandular cells and epithelial cells,
which line the air passages and gastrointestinal tract.
• Lymphomas: Cancers of the lymphoid organs such as lymph nodes, spleen, and
thymus, which produce and store infection-fighting cells. Lymphoma is cancer of
the lymphatic system, which is part of the immune system. The lymphatic system
is a network of nodes connected by vessels which drain fluid and waste products
from all the organs and structures of the body. It is also involved in producing a
type of white blood cell called lymphocytes that help protect against infections.
Lymphoma occurs when the lymph node cells or lymphocytes begin to multiply
uncontrollably,  producing  malignant  (cancerous)  cells.  Lymphoma  can  start
almost  anywhere  in the body and can spread  beyond the lymphatic  system to
other tissues and organs. Over time, lymphoma cells may replace the normal cells
in the bone marrow. This can result in the inability to produce red blood cells that
carry  oxygen,  white  blood  cells  that  fight  infection,  and  platelets  that  stop
bleeding.
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1.4 FREE RADICALS AND ANTIOXIDANTS2:
Oxidative stress is a crucial etiological factor to the pathophysiology of a variety
of degenerative pathological  conditions such as aging,  cancer,  coronary heart  disease,
Alzheimer’s  disease,  atherosclerosis  and  inflammation.  Human  body  has  multiple
mechanisms especially enzymatic and non enzymatic antioxidant systems to protect the
cellular molecules against reactive oxygen species (ROS) induced damage. However due
to  the  overproduction  of  reactive  species  and/or  inadequate  antioxidant  defense,  it
culminates in severe or continued oxidative stress. The harmful action of the free radical
can, however, blocked by antioxidant substances, which scavenge the free radicals and
detoxify the organism.
Figure1.1  Shows Free Radical Generation3
Figure1.2 Classification of Antioxidants
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1.4.1 Definition and Importance of Antioxidants:
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Antioxidants  are  substances  which  counteract  free  radicals  and  prevent  the
damage caused by them. These can greatly reduce the adverse damage due to oxidants by
crumbling them. Some non-enzymatic antioxidants like uric acid, vitamin E, glutathione
and CoQ10 are synthesized in the human body and they can also be derived from dietary
sources.  Polyphenols are the major class of antioxidants which are derived from diet.
Before  they  react  with  biologic  targets,preventing  chain  reactions  or  preventing  the
activation of oxygen to highly reactive products. Except for anaerobes, oxygen is vital for
all  the living systems. However,  the paradox of aerobic life  is  that  oxidative damage
occurs  at  the  key biological  sites,  threatening  their  structure  and  function.  Oxygenic
threat  is  met  by an  array  of  antioxidants  that  evolved  in  parallel  with  our  oxygenic
atmosphere4.  Our  body  implements  various  antioxidants,  some  of  which  are  dietary-
derived antioxidants to help restrain potential free radical damage that could occur in our
bodies. If one looks back into the evolution of human diet, it can be observed that in the
Paleolithic age human intake of plant-derived antioxidants is considered to have been
many times higher than current intake5. Organized agriculture has begun approximately
12,000 years ago, and stimulated a pace of dietary and social changes that deprived our
biological  ability  to  adapt  to  the  rapid  changes  in  environment.  This  has  led  to  the
hypothesis  that  various  common  diseases  of  civilization  are  rooted  in  a  chronic
divergence between our ancient nutritional programming and our contemporary dietary
input6,7. A  key  disparity  between  dietary  supply  and  physiological  need  may  be  in
antioxidant nutrients. Adding to this, in modern day environment, people are exposed to a
variety  of  toxins,  which  can  be  potent  oxidants.  If  one  combines  the  increasing
environmental  pressure  of  oxidant  damage  with  our  unbalanced  contemporary  food
supply, the value of antioxidant supplementation becomes apparent. These agents should
possess  the  characteristics  like  good  bioavailability,  stability  and  selectivity  to  the
damaged  or  transformed  cells.  Formulating  antioxidants  is  particularly  interesting
because  of  their  relative  lack  of  toxicity,  preventive  and  therapeutic  roles  in  diverse
diseases, and encouraging evidences from epidemiology.
1.4.2 Classification of antioxidants
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Antioxidants can be classified into two major groups,  i.e.,  enzymatic  and non-
enzymatic antioxidants.  Some of these antioxidants are endogenously produced which
include enzymes, low molecular weight molecules and enzyme cofactors. Among non-
enzymatic antioxidants, many are obtained from dietary sources. Dietary antioxidants can
be classified into various classes, of which polyphenols is the largest class8. Polyphenols
consist of phenolic acids and flavonoids. The other classes of dietary antioxidants include
Vitamins, carotenoids, organo sulfural compounds and minerals (Fig. 1). 
1.4.3 Role of Free Radicals and Antioxidants in Cancer:
Oxidative  stress  is  initiated  by  ROS  such  as  superoxide  anion  and  hydrogen
peroxide. Neither of these ROS is a strong oxidant, but they can be converted into more
dangerous oxidants by harmful reactions in tissues9. Superoxide can be produced from
molecular oxygen by diverse cell types via enzymatic systems including the respiratory
chain, xanthenes oxidase, cyclo - oxygenase and NADPH - oxidase. It rapidly dismutates
into H2O2, either spontaneously or enzymatically,  but if superoxide collides with nitric
oxide  the  formation  of  peroxy  nitrite  takes  place10.  H2O2 is  formed  as  a  product  of
superoxide dismutation, although some enzymes like monoamine oxidase can produce
H2O2 directly  from  their  substrates.  Fenton  or  Haber-Weiss  reactions  catalyzed  by
transition metals like iron convert H2O2 into extremely strong hydroxyl radicals, while
myeloperoxidase produces hypochlorus acid from H2O2. These radicals attack sensitive
cellular  targets  like  lipids,  proteins  and  nucleic  acids  causing  their  inhibition  and
accelerated degradation. Thus, oxidative stress inflicts multiple levels of cellular damage,
which propagates a vicious cycle. Oxidation of phospholipids and fatty acids produces
reactive lipid peroxides, which in turn initiate chain reaction of lipids peroxidation in
cellular membranes11.
Some selected antioxidants and their mechanisms of action:
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Antioxidant Mechanism of action
 
SOD Dismutation of superoxide to H2O2 
CAT Decomposes H2O2 to molecular oxygen and water 
NAC Scavenging of H2O2 and peroxide Deacetylation
of precursor for GSH synthesis
GSH Intracellular reducing agent 
Lycopene Trapping of singlet oxygen 
Ellagic             Acid Scavenging of H2O2 
Stimulation of glutathione-S-transferase
CoQ10 Inhibition of lipid peroxidation 
Reduces mitochondrial oxidative stress 
I3C Inhibition of DNA-carcinogen adduct formation 
Suppression of free radical production 
Genistein H2O2 scavenging 
Quercetin H2O2 scavenging, one of the potent antioxidant
Among polyphenols 
Vitamin C Scavenging of superoxide anion by forming 
Semi dehydro ascorbate radical which is subsequently 
Reduced by GSH 
Vitamin E Direct scavenging of superoxide 
Upregulation of antioxidant enzymes
Inhibition of lipid peroxidation
SOD=superoxide dismutase, CAT=catalase, NAC=N-acetyl cysteine, GSH= glutathione,
CoQ10=coenzyme Q10, I3C=indole-3-carbinol.
1.5 PRESENT STRATAGIES IN TREATMENT OF TUMOR:
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1.5.1 Adoptive Engineered T-Cell Targeting To Activate Tumor Killing12:
T-cells  can be used  to  treat  some malignant diseases but many  tumors  avoid
destruction  by  the  immune  system.   The  last  30  years of research has brought further
understanding of T-cells and consequently the adoptive transfer of immune T-cells has
shown that it may be effective  against  tumor  in  some malignancies,  for  example  in
melanoma  or   in   lymphomas.  The  development  of  gene  therapy  techniques  have
supported  the  idea  of  ‘engineered  T-cells’.  Attack  is  a  pre-clinical  research  project
focusing  on  the  development  of  immune  cell  therapies  based  on  the  concept  of
genetically engineered T-cells to target cancer The strategies that produce engineered T-
cells employ the transfer of tumor targeting receptors on the outside surface of the T-cells
using viral  vectors to help the T-cells  to bypass  the mechanisms of immune controls
triggered by the tumor.
Aim:
Attack aims to improve engineered T-cell  function and to perform pre-clinical
studies  which  will  underpin  future  clinical  trials.  With  this  in  mind,  attack  will  also
enhance  the understanding of  the mechanisms involved in  tumor evasion  of  immune
control. The  overall  objectives  are  broken  down  within  six  work  packages (WP):1.
Optimization  of   two  receptor  -  based  strategies  to  endow  the  T-cells  with  tumor
specificity  (WP1 and 2).  The first  strategy is  based in  engineering T-cells  to  express
recombinant  T-cell  receptors  complex  (TCR  α  and  β)  recognizing  MHC  restricted
antigens at the surface of the tumor cells (WP1). The other strategy is based on chimeric
immune receptors (CIR), which are scFv or small antibody molecules linked to the TCR
α (WP2).
Expected results:
The project started in November 2005 and so far a website has been created for
the dissemination of information within a secure portal for the members of the attack
project and external pages for dissemination to the general public. The  next  five  years
will  bring  different  sets  of  results  established  in  tumor cell lines and in mouse
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models as well as a variety of genetic and  molecular  data  testing  performance  and
specificity  of  the  two engineered T-cell strategies.
1. Animal models will give important clues on the fundamental mechanisms of
action of the engineered T-cells and the immune response they trigger. Mouse
models will allow comparison of relative efficacy of T-cells redirected with
scFv and TCR specific for the same antigen. 
2. Animal  studies will  also  enable  the  testing  of  different  protocols aimed
at  improving  the  engineered T-cell  killing  function  employing chemokines
or cytokines that can be applied to the clinic later. State-of-the-art imaging
technology, like the dorsal skin fold window chamber, will be used to follow
migration of the engineered T-cells in vivo and in real time experiments. 
3. The  development  and  testing  of  various  products  from  the  commercial
partners  will  define  unique  protocols  for  the  selection  and  expansion  of
engineered T-cells.
4. Finally  important  safety data on  auto-immunity,  immune  response  against
the different  parts of the receptor introduced in engineered  T-cells will be
collected  from  the  in  vivo  experiments  in order  to  gather pre-clinical data
indispensable for future clinical trials.
5.  Read outs  from these results  will  be in peer-review publications,  popular
articles  and  other  published  material  such  as  poster  presentation  at
international meetings.
1.5.2 Flavonoids:
• Flavonoids  are  found  in  higher  vascular  plants,  particularly  in  the  flower,
leaves  and  bark.   They  are  especially  abundant  in  fruits,  grains  and  nuts,
particularly in the skins.
• Beverages  consisting of  plant  extracts  (beer,  tea,  wine,  fruit  juice)  are  the
principle source of dietary flavonoids intake.  A glass of red wine has ~200
mg of flavonoids.
• Typical flavonoids intake ranges from 50 to 800 mg/day, which is roughly 5,
50 and 100 times that of Vitamins C, and E, and carotenoids respectively.
1.5.3 Flavonoids role in cancer13:
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 Few  diseases  are  feared  more  than  cancer  because  cancerous  diseases,  after
cardiovascular disorders and accidents, kill more people before a normal life span has
been reached. Besides, the progress of cancer is often accompanied by great  pain and
ugly disfiguration of the body. Yet, in principle, cancer is curable if it is discovered early
and treated with the best current therapeutic methods. However, radical cancer cure is
fraught with considerable life-threatening dangers, loss of organs, pain, and discomfort.
Besides, its treatment is expensive. Hence, it is understandable that many cancer patients
look for and try milder anticancer therapies that offer some promise of a moderate, 
Long - term life-saving cure.  The flavonoids  are  some of  the most  promising
anticancer  natural  products  that  have  been  tried.  Related  synthetic  substances,  e.g.,
flavone acetic acid, have been subjected to Phase I clinical trials already, and they may
soon become adopted into the general repertoire of cytostatic treatment.
1.5.4 Flavonoids role in anti oxidants:
a. Enhance or mimic antioxidant enzymes.
b. Direct scavenging of ROS.
c. Repair damaged cellular components.
d. Pro-oxidant metal deactivation
Flavonoids  and  related  compound are  effective  in  scavenging  DPPH radical14,
hydroxyl  radical  and  in  metal-chelating  capacity.  Flavonoids  are  found  to  exhibit
numerous  biological  activities  like  vasodilatory,  anticarcinogenic,  antiinflammatory,
antibacterial, immune-stimulating, antiallergic, and antiviral effects 15.
1.6 CELL LINES16:
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If the specified number of cells of inoculated in to sensitive mouse strain, tumors
can be developed rapidly as compared to chemical carcinogen-induced tumors and time
can saved using this model.
1.6.1 METHODS INVOLVED IN CELL LINES:
1) L-1210  and P-388 cell  lines  are  used.  These  cell  lines  are  derived  from mouse
lymphatic leukemia and have 100% growth fraction and tumor implanted with specified
number of L-1210 or P-388 cells can be predicted. The effective drug would retard the
tumor  growth  and  increase  the  life  span  of  the  animal.  A drug,  which  prolongs  the
lifespan of the animal by 20%, is taken for subsequent studies involving testing on other
transplantable tumors. Some other cell lines which can be inoculated to induce tumors are
B-16(melanoma), Lewis lung carcinoma and sarcoma-180, etc. The host mouse strain for
above type of cell lines is BDF, except Swiss for sarcoma-180. P-388 and L-1210 cell
lines  are  inoculated  intraperitoneally  and  sarcoma-180  as  subcutaneously.  The
experiment takes about 10 days for completion.
ILS (%) = 
[(Mean survival of treated group/ Mean survival of control group)-1] x100
For sarcoma-180 tumors, reduction of tumor size (tumor weight) is used to find out the
inhibiting activity of solid tumors as follows.
Tumor inhibiting activity = 
(average tumor weight of the treated group/average tumor weight of control group) x 100
1) Hollow-fiber technique: 
 Small  hollow  fibers  (tubes  1mm in  diameter  and  2cm  long  made  of  plastic,
polyvinylidene flouride), containing cells from human tumors are inserted underneath the
skin and in the body cavity of the mouse. Each candidate drug is administered at two
dosages and is tested against 12 target tumor cells in different hollow fibres. A total of
about 20 compounds / week are screened by this method. Compounds that  retard the
growth of the cells are recommended for the next level of testing. The average length of
this test is four days.
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2) Nude mouse model:   
Nude mice have been widely used to test the tumorogenicity of cells or for testing
of anticancer drugs. These mice are immunologically incompetent because of absence of
thymus. They neither show mitotic response in mixed lymphocyte reaction, nor generate
cytotoxic  effectors  cell.  Lack  of  helper  T  and  suppressor  T  cells  alters  the  antibody
response of the animals to antigen. They do not show contact sensitivity and do not reject
the  transplanted  material.  They  are  required  to  be  maintained  under  strictly  sterile
conditions and in a warm environment (26-280). 
Some other points regarding their use are:
a. Certain tumors like melanomas and colon carcinomas grow very well  in nude
mice, whereas prostate carcinoma and most types of leukemia grow very poorly.
b. Large numbers of cells, usually >106 are required to be inoculated beneath the
skin to get a successful tumor take.
c. Metastases are rarely observed.
d. Overall maintenance is very expensive.
1.7 INVITRO  METHODS  FOR  SCREENING  OF  NEW  ANTICANCER
MOLECULES16:
Though  animal  models  provide  more  predictable  results,  invitro  testing  is  still
preferred prior to invivo testing of a potential chemotherapeutic agent.  Invitro cultures
can be cultivated under a controlled environment (PH, temperature, humidity,  oxygen /
carbondioxide  balance  etc)  resulting  in  a  homogenous  batches  of  cells  and  thus
minimizing experimental errors.
Advantages: 
 Less time consuming 
 More cost effective 
 Small quantities of, and large number of compounds can be tested.
 These are easier to manage.
Disadvantages:
 Sometimes these methods may furnish false positive results (compounds show
no  activity  invivo)  or  false  negative  results  (compounds  show no  activity
invitro but show activity invivo as they need to be biotransformedin vivo to a
pharmacologically active compound).
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 The role of pharmacokinetics in determining drug effects cannot be evaluated
invitro.
 Geometry of solid tumors invivo is very different from that of cells growing
invitro in suspension or monolayer cultures.
An  ideal  invitro screening  method  should  be  simple,  economical,
reproducible, rapid and sensitive. The assay should be applicable to large number of
clinical  situation  as  close  as  possible.  The  choice  of  the  cell  lines  should  be
representative  of  clinical  situation  as  close  as  possible.  The  range  of  drug
concentrations  used  invitro  should  be  comparable  to  that  expected  for  in  vivo
treatment. The assay should be able to process a large number of samples quickly and
in an automated fashion. Data acquisition should be simple, easily interpreted and
applied. At present no such system is available. Even the most extensively studied
assays  will more often identify agents that will not  work in an individual patient.
However, the chemo sensitivity assays contribute to an active area of research and
routinely used for the screening of anticancer drugs.
The goal of a screening assay to test the ability of a compound to kill cells, at
the same time, the assay should be able to discriminate between replicating cells and
non-replicating cells  (quiescent  cells  that  are dead or dying -Apoptosis).  Different
assays takes advantage of various properties of cells as mentioned below.   
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Table 1.1.LIST OF INVITRO SCREENING METHODS
S.No Cell Properties Assay
1.
Enzymatic
properties
Tetrazolium salt assay(MTT)
2.
Protein content/
synthesis
Sulphorhodamine B assay
3.
DNA content/
synthesis
3H-Thmidine uptake Newer
fluorescent analogues with flow cytometry
4. Membrane integrity Dye exclusion tests
5.
Clonogenic
properties
Clonogenic assay
6. Cell division Cell counting assay
1.8 ROLE OF IL-2 IN TUMOROGENESIS17:
IL-2 is a protein of 133 amino acids (15.4 kDa).  It is produced mainly by T-cells
expressing the surface antigen CD4 following cell activation by mutagens or allogens
under physiological conditions. IL-2 displays significant anti-tumor activity for a variety
of tumor cell types since it supports the proliferation and clonal expansion of T-cells that
specifically attack certain tumor types.  Human IL-2 is active on mouse cells, mouse IL-2
is species-specific and is inactive on human cells. At the amino acid sequence level, there
is approximately 60% similarity between mouse and human IL-2.  
1.9 SIGNIFICANCE OF THE PLANTS CHOSEN FOR THE PRESENT STUDY:
The  plant  Cassia  fistula  linn was  reported  that,  it  has  a  rich  amount  of
Flavanoids18.  The leaves showed mainly the presence of Anthraquinone glycosides and
Flavonoids.  The  Anthraquinone  glycoside  includes  rhein,  emodine,  physion,
chrysophanol  (marker),  Obtusin,  chrysoobtusin,  chryso-obtusin-2-O-β-D-glucoside,
obtusifolin  and  chryso-obtusifolin-2-O-  β  -Dglucoside103 also  suggest  that  Cassia
fistula linn species have an anti cancer activity. 
1.10  SIGNIFICANCE  OF  THE  DALTON’S  LYMPHOMA  ASCITES  TUMOR
CELL LINES (DAL) CHOSEN FOR THE PRESENT STUDY:
1.10.1 Dalton’s lymphoma Ascites tumor cell lines (DAL):
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 It is a tumor cell line originally grown from a tumor of the thymus. 
 It is propagated by growing as ascites tumor in mice. 
 We can induce both ascites tumor and solid tumors using DAL cells.
 It is easy to maintain in vivo.
1.10.2 Maintenance of cell lines:
Tumor Cell Line and their Maintenance, Dalton’s lymphoma ascites tumor cell
lines  (DLA),  originally  obtained from Amala  Cancer  Institute,  Thrissur,  Kerala  were
propagated as transplantable tumors in the peritoneal cavity of the mice were used for the
study. The tumor cell lines were maintained by serial peritoneal cavity i.p transplantation
in  mice.  Full-grown  tumor  cell-line  were  aspirated  mouse  by  injecting  PBS  in  to
peritoneal cavity make cells to suspend in  PBS, take that suspended solution  and count
the number of  cells present in one ml by using tryphan blue exclusion method and adjust
the cell count to 1×106 by using PBS were  inject intraperitoneally in to a new healthy
mouse.
1.11 OBJECTIVE OF WORK:
Cancer  is  one  of  the  major  diseases  and  challenging  to  medicinal  system  to
produce potent and the site specific anti-cancer drugs. Vast number investigations are
going on to find out the potent and safer anti-cancer drugs.
In this cancer studies, till now most of the synthetic drugs produce undesirable
side effects. At the same time from plant source produce a potent and safer anti cancer
drugs than compare to synthetic drugs. So in this present study, plant source was selected.
Cassia fistula linn leaves have rich amount of Flavanoids, phenolic compounds and other
active chemical constituents. 
Flavanoids have a capacity to elevate the anti oxidant levels and prevent the free
radical reactions. And also reported that Flavanoids have a anticancer activity a specially
in breast cancer. So the present study Cassia fistula linn have high amount of Flavanoids
content and also it proved in several hypoglycemic hypolipidimic studies. 
Till now, there is no anti tumor and antioxidant study was reported on Leaves of
Cassia fistula linn, for that reason this present study chooses Antitumor and Antioxidant
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Status of  Cassia fistula linn leaves against Dalton’s Lymphoma Ascites-Induced Ascitic
Tumor in Mice.
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1.12 PLAN OF WORK
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Dalton’s lymphoma ascites tumor cell 
lines (DAL)
METHOD – I
DAL-INDUCED ASCITIC 
TUMOR IN MICE
1x 106 Cells/mouse(I.P)
METHOD – II
DAL-INDUCED SOLID 
TUMOR IN MICE
2x 106 Cells/mouse(S.C)
2. Determination
Of survival time
(each group contain 6
mice)
1. Determination
Hematological & in
vivo-antioxidant
(each group contain 6
mice)
GROUP – I
DALONLY
GROUP – II
DAL + 5FU 20mg/kg(I.P)
GROUP – III
DAL+Cassia fistula
linn250mg/kg(P.O)
GROUP – IV
DAL+ Cassia fistula linn
500mg/kg (P.O)DALONLY
GROUP-II
DAL + 5FU20mg/kg (i.p)
GROUP-III
DAL+ Cassia fistula linn
250mg/kg(p.o)
GROUP – IV
DAL+ Cassia fistula linn
500mg/kg(p.o)
GROUP – I
Normal Mouse
GROUP-II
DAL ONLY
GROUP-III
DAL+ Cassia fistula linn
20mg/kg(I.P)
GROUP – IV
DAL+ Cassia fistula linn
250mg/kg(p.o)
GROUP – V
DAL + Cassia fistula linn
500mg/kg(p.o)
1. Tumor volume
1. Body weight analysis
2. Determination of
mean survival time
(MST)
3. Tumor Volume
4. Viable and Non-viable cell count
5. Hematological parameters
6. Biochemical parameters
7. Invivo anti oxidant studies
8. histological observation
2. REVIEW OF LITERATURE
PLANT PROFILE:
Cassia fistula  Linn., (Fabaceae, Caesalpinioideae), a very common plant known
for its medicinal properties is a semi-wild in nature. It  is distributed in various regions
including Asia, South Africa, China, West Indies and Brazil 19. It is commonly known as
Amultas and in English popularly called “Indian Laburnum” has been extensively used in
Ayurvedic system of medicine for various ailments. It is deciduous and mixed-monsoon
forests  throughout  greater  parts  of  India,  ascending to  1300 m in  outer  Himalaya,  is
widely used in traditional medicinal system of India20.
Geographical distribution: In deciduous and mixed monsoon forests throughout greater
parts of India, ascending to 1300 m in outer Himalaya.  In  Maharashtra,  it occurs as a
scattered  tree  throughout  the  Deccan  and  Konkan21.  The  plant  is  cultivated  as  an
ornamental throughout India22.
TAXONOMIC POSITION
Kingdom: Plantae
Subkingdom: Tracheobinota
Super Division: Spermatophyta
Division:Mangoliophyta
Class: Magnoliopsida
Sub Class:Rosidae
Order:Fabales
Family: Fabacae
Genus: Cassia
Species: fistula
Dilshad P, M. Pharm Thesis, 2014, JKKNCP, Komarapalayam.                                     Page 18
Vernacular Names
Bengali: Amultash,sondal,sonali
English: Golden shower, Indian laburnum
Gujarati: Girmala
Hindi: Bandarlathi,bharva,suvarnaka
Malayalam: Tengguli,rajah
Sanskrit: Saraphala,survanaka,argwadha ,rajtaru
Tamil: Kavani,konnai,tirukontai,sarakkonne, Raelachettu
Telugu: Kakkemara
Marathi: Bahava
Punjabi: Amaltaas, Kaniyaar, Girdnalee
Oriya: Sunaari
Urdu: Amaltaas
Arab: Khayarsambharchaiyaphruek,khuun
Thai: Canâfístulamansa,chácara ,Guayaba
Spanish: Bâtoncasse, cassedoux, casseespagnol cimarrona
Trade name: Indian laburnum
Morphology
It is a deciduous tree with greenish grey bark, compound leaves, leaf lets are each
5-12 cm long pairs. A semi - wild tree known for its beautiful bunches of yellow flowers
and also used in traditional medicine for several indications 23. A fruit is cylindrical pod
and seeds many in black, sweet pulp separated by transverse partitions. The long pods
which are green, when unripe, turn black on ripening after flowers shed 24. Pulp is dark
brown in  colour,  sticky,  sweet  and mucilaginous,  odour characteristic,  and somewhat
disagreeable 25. Drug occurs in flat or curved thick pieces; outer surface smooth to rough
with  warty  patches;  greenish  grey  to  red;  inner  surface  rough,  reddish  with  parallel
striations; fracture, laminate; odour, sweet and characteristic; taste, astringent 26. A tree 6-
9 m high; trunk straight; bark smooth and pale grey when young, rough and dark brown
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when old; branches spreading, slender. Leaves 23-40 cm long; main rhachis pubescent;
stipules  minute,  linear  -oblong,  obtuse,  pubescent.  Leaflets  4-8 pairs,  ovate or  ovate-
oblong, acute, 5-12.5 by 3.8- 9.5cm, bright green and glaborous above, paler and silvery
pubescent  beneath when young,  the midrib  densely pubescent  on the underside,  base
cuneate; main nerves numerous, close, conspicuous beneath; petiolules 6-10 mm long,
pubescent or glaborous. Flowers in lax racemes 30-50 cm. long; pedicels 3.8- 5.7 cm.
long, slender, pubescent and glaborous. Calyx 1 cm long divided to the base, pubescent;
segments oblong, obtuse. Corolla 3.8 cm across, yellow; stamens all antheriferous. The
pods are pendulous, cylindric, nearly straight, smooth, shining, brown-black, indehiscent,
with numerous (40-100) horizontal seeds immersed in a dark coloured sweetish pulp.
Seeds broadly ovate, 8mm. long, slightly less in breadth, and 5mm thick 27. The fruit pods
are 40-70 cm long and 20-27mm in diameter,  straight  or slightly curved,  smooth but
finely striated transversely,  the striations appearing as fine fissures. The rounded distal
ends bear a small point marking the position of the style. The dorsal suture appears as a
single vascular strand and the ventral suture as two closely applied strands. Internally the
pod is divided by thin, buff coloured, transverse dissepiments at intervals of about 0.5cm.
Each  compartment  contains  one  seed  which  is  flat,  oval,  reddish  brown  with  a  well
marked raphe. The seed contains a whitish endosperm in which the yellowish embryo is
embedded 28.
Traditional Medicinal Uses
The root is prescribed as a tonic, astringent, febrifuge and strong purgative  29-33.
Extract of the root bark with alcohol can be used for backwart fever. The roots are used in
chest pain, joint pain, and migraine and blood dysentery. The extract of the root lowered
the blood sugar level up to 30 percent34. Root is useful in fever, heart diseases, retained
excretions  and  biliousness35.  The  aqueous  extract  of  the  root  bark  exhibits  anti-
inflammatory  activity.  The  root  is  used  in  cardiac  disorders  biliousness,  rheumatic
condition,  hemorrhages,  wounds,  ulcers  and boils  and various  skin diseases36.  Cassia
fistula Linn leaves are crushed to prepare a thick paste and mixed with coconut oil. This
paste  is  applied  over  the  burnt  skin  twice  a  day37,  38.  The  stem bark  is  used  against
amenorrhoea,  chest  pain  and  swellings.  The  bark  possess  tonic  and  antidysentric
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properties,  it  is also used for skin complaints, the powder or decoction of the bark is
administered in leprosy, jaundice, syphilis and heart diseases39.
Cassia fistula Linn
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The leaves extract reduced mutagenecity in E. coli 40. The leaves are laxative and
used externally as emollient, a poultice is used for chilblains, in insect bites, swelling,
rheumatism and facial paralysis41-43. Leaves posses anti periodic and laxative properties,
the  leaves  are  used  in  jaundice,  piles,  rheumatism  ulcers  and  also  externally  skin
eruptions,  ring  worms,  eczema.  The  leaves  and  bark  mixed  with  oil  are  applied  to
pustules, insect bites44.  Juice of leaves is  used in skin diseases45,  46.  Juice of leaves  is
useful as dressing for ringworm, relieving irritation and relief of dropsical swelling. The
pulp of the fruit around the seeds is a mild purgative  47. Leaves and flowers are both
purgative like the pulp48.  Ashes  from burnt  pods mixed with little  salt  are  used with
honey taking 3- 4 times to relieve cough. Fruits are used as catharatic and in snake bite49.
Flowers  and  pods  are  used  as  purgative,  febrifugal,  biliousness  and  astringent.  The
ethanolic 50% extract of pods show antifertility activity in female albino rats. The heated
pods are applied to swellings on the neck due to cold. The fruits are reported to be used
for  asthma50.  Pulp is  given in disorders  of liver.  The drug is  used as analgesic  as an
antipyretic, it is a remedy for malaria and fever. It  is also applied in blood poisoning,
anthrax  and  antidysentric,  leprosy  and  antidiabetic,  for  the  removal  of  abdominal
obstruction51.  The extract of the flower inhibits the ovarian function and stimulate the
uterine function in albino rats. Fruits are used in the treatment of diabetes, antipyretic,
abortifacient,  demulcent  lessens  inflammation  and  heat  of  the  body;  useful  in  chest
complaints, throat  troubles,  liver complaints, diseases of eye  and gripping52.  The fruit
pulp  is  used  for  constipation,  colic,  chlorosis  and  urinary  disorders53.  The  seeds  are
emetic, used in constipation and have cathartic properties. The seeds are slightly sweet
and possess laxative, carminative, cooling, improve the appetite and antipyretic activity54.
They are useful in jaundice, biliousness, skin disease and in swollen throat55. A seed dried
produce marked hypoglycaemic activity. Seed powder is used in amoebiasis.
Phytochemical Profile
A majority  of  the  ascribed  biological  effects  of  C.  fistula  extracts  have  been
attributed to their  primary and secondary metabolite  composition.  Primary metabolite
analysis has essentially been focussed on the seed, pollen, fruit, leaf and pod. The seeds
are rich in glycerides with linoleic, oleic, stearic and palmitic acids as major fatty acids
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together with traces of caprylic and myristic acids. It has been reported that the stem bark
of C. fistula is also a potential source of lupeol, ß-sitosterol and hexacosanol. In an earlier
study it was reported that one of the major carbohydrates in the seeds was galactomannan
consisting of 8 different types of sugar moieties. A detailed biochemical analysis of the
flower’s  pollen,  suspected  to  play  a  significant  allergenic  role,  showed  a  protein
composition of 12% with appreciable amounts of free amino acids such as phenylalanine,
methionine, glutamic acid and proline. Carbohydrate, lipid and free amino acid contents
were of the order of 11.75, 12 and 1.42%, respectively56. The edible fruit tissue of the
Indian laburnum fruit was reported to be a rich source of potassium, calcium, iron and
manganese than fruits like apple, apricot, peach, pear and orange The protein (19.94%)
and carbohydrate (26.30%) contents are indicative of the potential of the fruit to be an
important  source  of  nutrients  and  energy.  Apolar  compounds  including   5-
nonatetracontanone, 2- hentriacontanone, triacontane, 16- hentriacontanol and sitosterol
along with an oil (probably an isoprenoid compound) showing antibacterial activity have
also  been  isolated  in  C.  fistula  pods57.  C.  fistula  plant  organs  are  known  to  be  an
important source of secondary metabolites, notably phenolic compounds. Fistucacidin, an
optically inactive leucoanthocyanidin (3, 4, 7,8,4’pentahydroxyflavan) was first extracted
from the heartwood. The presence of kaempferol and a proanthocyanidin whose structure
has been established as a leucopelargonidin tetramer having a free glycol in the acetone
extract  of  the  flower  has  been  documented.  Proanthocyanidins  containing flavan-3-ol
(epiafzelechin and epicatechin) units with an abnormal 2S-configuration have also been
observed  in  pods  together  with  the  common flavan-3-ols  and  proanthocyanidins  like
catechin, epicatechin, procyanidin B-2 and epiafzelechin58.
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LITERATURE REVIEW:
Siddhuraju P.,et al studied that , the investigation suggest that the antioxidant properties
of 90% ethanol extracts of leaves,  and 90% methanol extracts of stem bark, pulp and
flowers from Cassia fistula. The antioxidant activity power was in the decreasing order of
stem bark, leaves, flowers and pulp and was well correlated with the total polyphenolic
content of the extracts. The reason for low antioxidant activity in the flower and pulp
fractions could be the presence of some pro oxidants, such as chrysophanol and reducing
sugars which dominate the antioxidant compounds present in the extracts. Thus, the stem
bark had more antioxidant activity in terms of reducing power, inhibition of peroxidation,
O2 and DPPH radical scavenging ability 59. It has been reported that aqueous extract of
Cassia fistula  Linn.  flowers  (ACF)  was  screened  for  its  antioxidant  effect  in  alloxan
induced diabetic rats. An appreciable decrease in peroxidation products vizthiobarbituric
acid reactive substances, conjugated dienes, hydroperoxides was observed in heart tissues
of ACF treated diabetic rats. The decreased activities of key antioxidant enzymes such as
superoxide  dismutase,  catalase,  glutathione  peroxidase,  glutathione  reductase  and
glutathione in diabetic rats were brought back to near normal range upon ACF treatment.
These  results  suggest  that  ACF  has  got  promising  antioxidative  activity  in  alloxan
diabetic rats.
Barthakur N.,et al studied that, the methanol extract of seeds of C. fistula was tested for
different  pharmacological   actions  in  mice.  The  extract  significantly  potentiated  the
sedative actions of sodium pentobarbitone, diazepam, meprobamate and chlorpromazine.
It  also potentiated analgesia  induced  by morphine  and pethidine in  a  dose-dependent
manner. The extract also influenced behaviour in mice60.
Kumar A.,et al studied that, the potential of Cassia fistula to treat the infected wound on
albino rat model was investigated61. The alcohol extract of C. fistula leaves was analyzed
for antibacterial  effect  against  Staphylococcus aureus  ATCC 29213 and  Pseudomonas
aeruginosa  ATCC 27853.  Formulated ointment was topically applied on the infected
wound. Wound reduction rate,  histological  analysis,  biochemical  analysis,  and gelatin
zymography were obtained to assess the healing pattern.  C. fistula  treated rats showed,
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better wound closure,  improved tissue regeneration at  the wound site,  and supporting
histopathological  parameters  pertaining  to  wound  healing.  Biochemical  analysis  and
matrix  metalloproteinases  expression correlated  well  with  the  results  thus  confirming
efficacy  of  C.  fistula  in  the  treatment  of  the  infected  wound.  Along  with  the  other
activities such as antitumor, antioxidant, hypoglycemic,  hepatoprotective, antibacterial,
hypocholesterolaemic,  and  antidiabetic  activity,  the  healing  potential  of  C.  fistula
provides a scientific rationale for the traditional use of this plant in the management of
infected dermal wound and can be further investigated as a substitute to treat infected
wounds without using synthetic antibiotics.
Hegde Chaitra R.,studied that ,  the  hexane, chloroform, ethyl acetate,  methanol and
water extracts from the flower of  Cassia fistula  were tested against bacteria and fungi.
All  the  extracts  exhibited antibacterial  activity against  Gram positive  organisms with
minimum inhibitory concentrations  (MIC)  between 0.078 and 2.5 mg/ml.  Among the
Gram negative bacteria, only  Pseudomonas aeruginosa  was susceptible to the extracts.
Ethyl acetate crude extract was fractionated using chromatographic techniques. A crystal
was  isolated,  which  was  confirmed  as  4-hydroxy  benzoic  acid  hydrate  using  X-ray
crystallography.  It  exhibited  antifungal  activity  against  Trichophytonmentagrophytes
(MIC 0.5 mg/ml)  and  Epidermophytonfloccosum  (MIC 0.5 mg/ml).  Three lectins,  i.e.
CSL-1, CSL-2 and CSL-3, purified from the  Cassia fistula  seeds, were tested for their
antibacterial  activities  against  different  pathogenic  bacteria,  i.e.  Bacillus  subtilis,  B.
megaterium,  Streptococcus  haemolyticus,  Streptococcus  aureus,  Sarcinalutea,
Shigellasonnei,  scherichia  coli,  Klebsiellasp.,Shigellashiga,  Shigellaboydii,
Shigellaflexneri,  Shigelladysenteriae,  Salmonella  typhiandPseudomonas  aeruginosa,
using 30 micro g/disc. CSL-3 was active against all bacterial strains and showed strong
activity against  B. megaterium,  Streptococcus haemolyticus  and  Shigellaboydii.  CSL-2
showed poor activity against most of the bacterial strains and has strong activity against
only  Streptococcus  haemolyticus.  CSL-1 was  inactive  against  all  the  bacterial  strains
except Streptococcus haemolyticus and Sarcinalutea. All the lectin significantly affected
the mortality rate of brine shrimp. Among them, CSL-2 was highly toxic (6.68 micro
g/ml) followed by CSL-1 (10.47 micro g/ml) and CSL-3 (13.33 micro g/ml). Aqueous
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extract of C. fistula in disc diffusion method showed significant activity against S. aureus
but not against other bacteria tested. Alcoholic extract showed greater inhibition against
S.aureus compared to aqueous extract. One of the field isolates of S. aureus resistant to
chloramphenicol  was  also  susceptible  to  the alcoholic  extract  of  C. fistula.  Zones  of
inhibition of alcoholic and aqueous extracts were in the range of 7.0-12.0 mm and 7.0-
11.6 mm, respectively. MIC values of the alcoholic extracts against S. aureus were in the
range of 0.78-6.25 mg/ml 62, 63.
Sen A.B., et al studied that , the effects of methanolic extract (ME) of Cassia fistula seed
on the growth of Ehrlich ascites carcinoma (EAC) and on the life span of tumor bearing
mice were studied. ME treatment showed an increase of life span, and a decrease in the
tumor volume and viable tumor cell count in the EAC tumor hosts. Cytological studies
have  revealed  a  reduction  in  the  mitotic  activity,  and  the  appearance  of  membrane
blebbing and intra cytoplasmic vacuoles in the treated tumor cells. Improvement in the
haematological parameters following ME treatment, like haemoglobin content, red blood
cell  count  and  bone  marrow  cell  count  of  the  tumor  bearing  mice  have  also  been
observed.  The results  of the present  study suggest  that  ME of  C.  fistula  seed has  an
antitumor activity.  Haematological studies have revealed that out of the three doses of
ME, ME at the dose of 100 mg/kg has shown better results than at the doses of 200 and
300 mg/kg. The exact mechanism by which ME mediates its antitumor effect is still to
beelucidated. Cytological changes indicate that ME might be having a direct tumorocidal
effect on the tumor cells 64, 65.
Gupta M., et al studied that , the petroleum ether extract of seeds of Cassia fistula was
screened for the antifertility activity in proven fertile female albino rats at the doses 100,
200 and 500 mg/kg b.wt./day. Oral administration of the extract to mated female rats on
days  1-5 of pregnancy resulted in a decline in the fertility index, numbers of uterine
implants and live foetuses in a dose dependent manner as was confirmed by laparotomy
on day 15 of pregnancy. The extract (100 mg/kg b.wt.) exhibited weak estrogenic activity
when given alone and tested in immature bilaterally ovariectomized female albino rats,
but  exhibited  slight  antiestrogenic  activity  when  administration  along  with  estradiol
valerate  (0.1  mg/kg  b.wt.).  Blood  sugar  and  haematological  parameters  were  within
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normal range.  Thus, the results  of the present study indicate that  the petroleum ether
extract of  Cassia fistula seeds possesses pregnancy terminating effect by virtue of anti-
implantation activity66.
Abu Sayeed M., et al studied that, the effectiveness of Cassia fistula in the treatment of
leishmaniasis, the efficacy of concentrated boiled extract and hydroalcoholic extract of C.
fistula  on  leishmaniasis  was  compared  with  intralesional  injection  of  Glucantime
[meglumineantimonate]  in this  study.  63.6% of patients treated with the concentrated
boiled extract, 52.7% of patients treated with the hydroalcoholic extract, and 45.5% of
patients  treated  with  Glucantime.  In  total,  22  patients  (40%)  given  the  concentrated
boiled extract of  C. fistula, 20 patients (36.4%) given the hydroalcoholic extract of  C.
fistula,  and 36 patients (65.5%) of the Glucantime group showed complete cure.  The
efficacy in the third group was significantly higher than the first (P<0.02) and second
groups  (P<0.005),  but  there  was  no  difference  between  the  efficacy  of  concentrated
boiled extract and hydroalcoholic extract of C. fistula. These results show that this plant
could  be  used  topically  along  with  Glucantime  for  decreasing  the  time  and  dose  of
treatment with Glucantime. The potential of Cassia fistula boiled extract in the treatment
of  cutaneous  leishmaniasis,  to  evaluate  the  efficacy  of  intra  lesional  meglumine
antimonate –
C. fistula  fruit gel combination for the treatment of cutaneous leishmaniasis. A total of
140 patients with cutaneous,  one group received intra  lesional meglumine antimonate
injection and  C. fistula  fruit gel, and the second group (control) was treated with intra
lesional meglumine antimonite plus placebo gel. Improvement was defined as complete
cure, partial cure and treatment failure. At week 12, forty-seven (67.1%) patients in the
experimental  group  achieved  complete  cure,  compared  to  29  (41.4%)  patients  in  the
control  group  (P<0.001).  Results  indicate  that  the  C.  fistula  fruit  gel  increases  the
efficacy  of  intra  lesional  meglumine  antimonate  for  the  treatment  of  cutaneous
leishmaniasis.  Combination  therapy  with  intra  lesional  meglumine  antimonate  and
C.fistula  fruit  gel  should  be  considered  for  the  treatment  of  acute  cutaneous
leishmaniasis67.
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3. MATERIALS AND METHODS
3.1 Collection and authentication: 
The Leaves  of  Cassia fistula  linn were  collected  locally and  authenticated  by
Dr.N.Elangovan, M.Sc., Ph.D. Assistant professor, Department of Biotechnology, Periyar
University, Salem , Tamilnadu, India. 
3.2 Extraction Procedure:
3.2. A. Extraction of steam and bark of Cassia fistula Linn.,
The Leaves of Cassia fistula linn were locally collected in month of November.
The Leaves  were  chopped,  air  dried for  a  week and powered.  The powder was then
extracted in petroleum ether to remove fatty material using soxhlet extractor. Then the
material was air dried and again subjected to extraction with methanol by using soxhlet
continuous extraction until  the colour of the material disappears.  The obtained extract
was concentrated to remove excess of remaining methanol.
3.3. Preliminary Phytochemical analysis  of Methanolic extract of Leaves of  Cassia
fistula Linn.
3.3.1 Chemical tests:
  A) Test for carbohydrates:
1) Molisch Test:
In this a small amount of leaves of cassia fistula linn extract is treated with
a -naphthol and concentrated sulphuric acid along the sides of the test tube. Purple colour
or  reddish violet  colour  at  the junction between  two liquids  was formed.  It  indicates
presence of carbohydrates. 
2) Fehling’s Test:
In this small amount of test extract is treated with Equal quantity of Fehling’s
solution  A  and  B is  and  Heat  gently,  brick  red  precipitate  was  formed.  It  indicates
presence of carbohydrates. 
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 3) Benedict’s test:
To the 5 ml of Benedict’s reagent, added 8 drops of extraction solution.
Mixed  well,  boiling  the  mixture  vigorously  for  two  minutes  and  then  cool.  Red
precipitate was formed. It indicates presence of carbohydrates. 
4) Barfoed’s test:
To the 5 ml of the Barfoed’s solution added 0.5 ml of extraction solution
and mixed well and heated to boiling, red precipitate was formed. It indicates presence of
carbohydrates. 
B) Test for Alkaloids:
About  one  gram  of  the  powdered  sample  was  extracted  with  10  mL  of  10%
hydrochloric acid by boiling for five minutes on a water bath. The  extract was  filtered
and  the pH of  the  filtrate was adjusted  to about 6 by adding a  few drops of dilute
ammonia   solution  and   tested  with   litmus  paper  after  which   few   drops   of
Dragendorff’s,   Mayer’s  and Wagner’s  reagent were  added  separately  to aliquots  of
the  filtrate   in  the  test   tubes.   A  reddish  brown,   cream  and  reddish  brown
precipitate respectively indicates a positive test. 
C) Test for Steroids and Sterols:
1) Libermann Burchard test:
Leaves of Cassia fistula linn is dissolved in 2 ml of chloroform in a dry test
tube. Then added10 drops of acetic anhydride and 2 drops of concentrated sulphuric acid.
The solution becomes red, then later it was not changed to blue and bluish green colour it
indicates absence of steroids and sterols.  
2) Salkowski test:
           Leaves of Cassia fistula linn was dissolved in chloroform and adds equal
volume of conc. sulphuric acid. Bluish red cherry red and purple color is not formed in
chloroform  layer,  and  also  green  fluorescence  was  not  formed  indicate  absence  of
steroids and sterols.
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D) Test for Glycosides 
1) Legal’s test:
The extract Sample is dissolved in pyridine sodium nitropruside solution is
added to it and made alkaline. Pink red colour is produced. Indicates presence of
glycosides.
2) Baljet test: 
To the extract  sample,  sodium picrate solution is  added.  Yellow to orange
colour is produced. Indicates presence of glycosides.
3) Borntrager test:
Added a few ml of dilute sulphuric acid to the test solution. Boiled, filtered
and extract the filtrate with ether or chloroform.  Then organic layer is separated to
which ammonia is added, pink, red or violet colour is produced in organic layer.
Indicate presence of glycosides. 
4) Keller Killiani test:
Sample  is  dissolved  in  acetic  acid  containing  trace  of  ferric  chloride  and
transferred to the surface of concentrated sulphuric acid. At the junction of liquid reddish
brown color is produced which gradually becomes blue. Indicate presence of glycosides.
E) Test for Saponins:
About one gram of the powdered sample was boiled with 10 ml of distilled water
for ten minutes. The samples were filtered while hot, cooled and the following tests were
carried out.
1) Frothing:
 2.5  mL  of  the  filtrate  was  diluted  to  10mLs  with  water  and  was  shaken
vigorously for 2 minutes. Frothing observed indicates a positive test. 
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2) Emulsification: 
2.5mL of the filtrate was shaken vigorously for 2 minutes with a few drops of
olive oil. An emulsified layer indicates a positive test. 
 F) Test for Flavanoids:
A  small  quantity  of  the  extract was  dissolved  in  dilute  sodium  hydroxide
and   hydrochloric  acid  was  added  to  the  mixture.  A  yellow  solution  that  turns
colourless on addition of hydrochloric acid indicates the presence of flavonoids. 
    G) Test for Triterpenoid:
In the test tube, 2 or 3 granules of tin was added, and dissolved in a 2ml of thionyl
chloride  solution  and  test  solution  was  added.  Pink  colour  is  produced  which
indicates the presence of Triterpenoid.
H) Test for Protein and Amino acid:
1) Biuret test:
Added 1 ml of 40% sodium hydroxide and 2 drops of 1% copper sulphate to the
extracts, a violet colour formed indicates the presence of proteins.
2)Ninhydrin test: 
Added 2 drops of freshly prepared 0.2% ninhydrin reagent to the extracts and heated.
A blue colour developed indicating the presence of proteins, peptides or amino acids.
3) Xanthoprotein test:
To the extracts, added 20% of sodium hydroxide. Orange colour was formed indicates
presence of aromatic amino acid.
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3.4. DETERMINATION OF ACUTE ORAL TOXICITY (LD50) OF LEAVES OF
Cassia fistula linn 68
Table 3.1.Test substance details
Name of the test substance
Methanolic  extract  of  Leaves  of  Cassia
fistula Linn.
Colour of the test substance Brownish green
Nature of the test substance Sticky
Table 3.2.Experimental protocol
Name of the study Acute toxicity
Guideline followed OECD  423  method-acute  toxic  class
method
Animals Healthy  young  adult  Swiss  albino  mice,
nulliparous, non-pregnant
Body weight 25-30 g
Sex Female
Administration of dose and volume 2000  mg/kg  body weight,  single  dose  in0.5 ml
Number of groups and animals 3 groups and 9 animals
Route of administration Oral by using mice oral feeding needle
Vehicle Distilled water
Table 3.3.Housing and feeding conditions
Room temperature 22°C  ±  3°C
Humidity 40-60%
Light 12 h : 12h (light : dark cycle)
Feed Standard  laboratory  animal  food  pellets
with water ad libitum
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Table 3.4.Study period and observation parameters
Initial once observation First 30 minutes and periodically 24 h
Special attention First 1-4 h after drug administration
Long term observation Upto 14 days
Direct observation parameters
Tremors,  convulsions,  salivation,  diarrhea,
lethargy, sleep and coma.
Additional observation parameters
Skin  and  fur,  eyes  and  mucous  membrane,
respiratory,  circulatory,  autonomic and  central
nervous  systems,  somatomotor  activity  and
behavior pattern etc.
The  time  of  death,  if  any,  is  recorded.  (Complete  observations:  annexure  I).  After
administration of the  Leaves of  Cassia fistula Linn, food is withheld for a further 1-2
hours.
Study procedure:
Acute oral toxicity was performed as per organization for economic co-operation for
development (OECD) guideline 423 method. The Leaves of Cassia fistula linn substance
was administered in a single dose by gavage using specially designed mice oral needle.
Animals  are  fasted  3  h  prior  to  dosing  (food  was  withheld  for  3  h  but  not  water).
Following the period of fasting animals was weighed and test substance was administered
orally at a dose of 500, 1000 and 2000 mg/kg.  After the  Leaves of  Cassia fistula linn
substance  administration,  food  was  withheld  2  hrs  in  mice.  Animals  were  observed
individually after atleast once during the first 30 minutes, periodically during the first 24
hrs, with special attention given during the first 4 hrs, and daily thereafter, for a total of
14 days.
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3.5.  ESTIMATION  OF  INVITRO ANTIOXIDANT  ACTIVITY  METHANOLIC
EXTRACTS OF LEAVES OF Cassia fistula linn.
3.5.1 DPPH photometric assay:69
Reagents:
• Diphenyl-2-picrylhydrazyl (DPPH)
• Ethanol 
Principle:
  DPPH is  purple in colour ( λ max 517 nm) and in the presence of a substance (A-H),
capable of donating an electron or a hydrogen atom, it loses its radical  character and
becomes colourless.  
Procedure:
 The free  radical  scavenging  activity  of  the  extract  was  measured  in  terms  of
hydrogen donating or radical scavenging ability using the stable DPPH radical method
(Blois, 1958). Sample stock solutions (1.0 mg/ml) were diluted to final concentrations of
50, 40, 30, 20, 10 µg/ml, in ethanol. One ml of a 0.3 mM DPPH ethanolic solution was
added to 2.5 ml of sample solutions of different concentrations, and allowed to react at room temperature.
After  30  minutes  the  absorbance  values  were  measured  at  518  nm  and  converted  into  percentage  of
antioxidant activity (AA) using the following formula: 
AA % = 100 - { [(ABS SAMPLE – ABS BLANK) X 100 ] / ABS CONTROL}
Ethanol  (1.0  ml) plus  compound solution (2.5 ml) was used for  blank.  DPPH
solution  (1.0  ml;  0.3  mm)  plus  ethanol  (2.5  ml)  was  used  for  negative  control.  The
positive controls were those using the standard solutions. Average percent of antioxidant
activity from three separate tests were calculated.
3.5.2 ABTS+ RADICAL SCAVENGING ASSAY: 
Scavenging of 2,2-azino-bis(3-ethylbenzo-thiazoline-6-sulfonic acid ) 
Diammonium salt (ABTS) Radical cation.70.
Reagents:
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• 4.9 mM ammonium persulfate solution
• 14 mM ABTS
Procedure:
 ABTS+ radical was freshly prepared by adding 5 ml of 4.9 mM ammonium persulfate
solution to 5 ml of 14 mM ABTS solution and kept for 16 h in dark. This solution was
diluted with ethanol (99.5%) to yield an absorbance of 0.70±0.02 at 734 nm and the same
was used for  the assay.  To 950 µl  of ABTS radical  solution,  added 50 µl  of  extract
solutions  (25-500  µg/ml)  and  the  reaction  mixture  was  vortexed  for  10 sec.  After  6
minutes the absorbance was recorded at 734 nm and compared with the control ABTS
solution. Percentage inhibition was calculated from the formula38.
Percentage inhibition= [1−(absorbance of test/absorbance of control)]×100
3.5.3 DCF/AAPH assay (TRAP)71:
Reagents:
1. Dichlorofluorescin-diacetate( DCF)
2. 0.01N NaOH
3. Sodium phosphate buffer (25 mM, pH 7.2)
Procedure:
An azo initiator, AAPH, was used to produce peroxyl radicals, and the scavenging
activity of the LEAVES OF  CASSIA FISTULA LINN extracts  was monitored via the
spectrophotometric analysis of 2,7- dichlorofluorescin-diacetate. The activation of DCF
was achieved by mixing DCF (3.41 µl of 50µg/ml solution) and NaOH (1.75 ml of 0.01N
solution) and allowing the mixture to stand for 20 min before adding 18.25 ml of sodium
phosphate  buffer  (25  mM,  pH  7.2).  The  reaction  mixture  contained  10µl  of  extract
(diluted to final concentrations of 500, 250, 100, 50 and 25 µg/ml), 170µl activated DCF
solution and 20 µl of 600 mM AAPH (adjusted to a final concentration of 60 mM). The
reaction was initiated by adding the AAPH solution. After 10 min, the absorbance was
read at 490 nm using a Specrophotometer. 
3.5.4  FERRIC REDUCING ABILITY OF PLASMA (FRAP) EXPRESSED AS A
FUNCTION OF TIME72
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Reagents:
1. Acetate buffer (500 mM/l) 
2. Tripyridyltriazine (TPTZ) (10 mM/l)
3. Ferric chloride (20 mM/l)
Procedure:
FRAP agent was prepared by mixing 25 ml of acetate buffer (500 mM/l) with 2.5
ml  of  tripyridyltriazine  (TPTZ)  (10  mM/l)  and  2.5ml  of  ferric  chloride  (20  mM/l)
solution.  The  reaction  mixture  contained  300  µl of  freshly prepared  FRAP  reagent
warmed to 37o C, added to 10  µl of test along with 30  µl of water. Absorbance of this
solution was taken at 593 nm, just after 4 min from the time of addition of FRAP reagent.
An increase in absorbance indicated enhanced reducing potential of plasma. Quantitative
calculation for each sample was done using an equation obtained from the standard curve
of Fe++-TPTZ.
                The equation used: Absorbance = 0.274 x µM of Fe++ + 0.114 [R2 = 0.974]
3.6  SCREENING  OF  IN-VITRO  CYTOTOXICITYOF  METHANOLIC
EXTRACTS OF LEAVES OF Cassia fistula linn73
3.6.1 Tryphan Blue Dye Exclusion Method
Requirements:
a) Daltons lymphoma ascites (DAL) cells
b) Phosphate buffer saline solutions
c) Haemocytometer
d) Tryphan blue solution (0.4%)
Procedure:
Dalton  lymphoma ascites  (DAL) cells  were aspirated  from  the  peritoneal
cavity  of mice and washed  three  times  in phosphate buffer saline. Take 0.2ml of cell
suspension (DAL), 0.3ml of PBS and 0.5ml of 0.4% Tryphan blue were mixed and kept
aside for 5min and not more than 15min. From this one drop of solution was taken on a
neubauer chamber and a cover slip is placed. This is placed on Haemocytometer and the
viable and non-viable cells were counted under 10X power. Viable cells don’t take colour
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and these cells appear in white colour on blue background. Non-viabe cells (dead cells)
take blue colour and give dark blue shading to the cells and cell count was calculated
using formula 
                       Cell count = No. of cells x Dilution factor × volume factor 
One million cells were  incubated with different  concentrations  of  the LEAVES
OF CASSIA FISTULA LINN extract  (10, 25, 50, 100 and 200 µg/ml) and the  volume
was made up to 1.0 ml using PBS & Control tubes contained only cell suspensions. The
assay mixture  was  incubated  for  3  hr  at  37° C .The viability of  the cells  was  then
determined  using  Tryphan blue dye exclusion method percentage   Cytotoxicity a was
calculated using formula.
                      % Cytotoxicity = (Total cells-Dead cells) ×100/Total cells
3.6.2 TETRAZOLIUM SALT ASSAY (MICROCULTURE TETRAZOLIUM TEST
OR MTT)74:
Principle: 
MTT  assay  is  an  internationally  accepted  invitro  method  for  anticancer  drug
screening. MTT assay utilizes a color reaction as a measure of viable cells.  The assay is
dependent  on  the  cellular  reduction  of  3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium  bromide,  a  tetrazolium  salt  to  a  blue  formazan  product  by  the
mitochondrial dehydrogenase of viable cells/metabolically active cells. The intensity of
blue colored formazan produced is directly proportional to the cell viability.
Procedure:
 The cells  from a particular  cell  line(HeLa)  when in log phase of  growth  are
trypsinized, counted in a hemocytometer and adjusted to appropriate density in a suitable
medium and then inoculated in different  multiwall  plates(usually 96-well  plates).  The
cells  are  treated  with  various  concentrations  of  LEAVES  OF  CASSIA  FISTULA
LINNfor 1day after which MTT dye is added in each well and plates are incubated at
370 for 4h in a CO2 incubator. The plates are then taken out of incubator and dark blue
colored formazan crystals  are thoroughly dissolved in Isopropanol of DMSO at  room
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temperature. The plates are then read on an ELISA reader at 570nm. The percent cell
viability with respect to control is calculated using the formula.
    % cell viability = (optical density of treated cells/optical density of control cells)
×100
3.7. EVALUATION OF IN VIVO ANTICANCER ACTIVITY OF METHANOLIC
EXTRACTS OF LEAVES OF Cassia fistula linn75.
 Animal used:
Inbred female Swiss mice of 2 months age, weighing
20  ±  5  g,  were  purchased  from  Govt  veterinary  college
Mannuthi, Thrissur, India, were used for the study. The mice
were  obtained  from the  stock  in  breed  colony,  which  was
maintained by mating brothers and sisters. They were housed
at room temperature of 22◦C under 12 hr light/12 hr dark cycle in the animal house. Mice
were fed with commercial pellet diet and water  ad libitum freely throughout the study.
All  animal  procedures  were  performed  after  approval  from the  IAEC  (institution  of
animal ethical committee) and in accordance with the recommendations for the proper
care and use of laboratory animals.
3.7.1. DAL - INDUCED ASCITIC ANTITUMOR MODEL75
a)  ADJUST CELL COUNT TO 1×106 cells:
Requirements:
a) Daltons lymphoma ascites (DLA) cells
b) Phosphate buffer saline solutions
c) Haemocytometer
d) Tryphan blue solution (0.4%)
Method:
0.5ml of 0.4% Tryphan blue, 0.3ml of PBS and 0.2ml of cell suspension were
mixed and kept aside for 5min and not more than 15min. From this one drop of solution
was  taken  on  a  neubar  chamber  and  a  cover  slip  is  placed.  This  is  placed  on
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Haemocytometer  and the viable and non-viable cells were counted under  10X power.
Viable  cells  doesn’t  take  colour  and  these  cells  appear  in  white  colour  on  blue
background Non-viable cells(dead cells) take blue colour and give dark blue shading to
the cells, cell count was calculated using formula.
              Cell count = No. of cells x Dilution factor × volume factor 
b)  DAL-induced ascitic antitumor model:
The  anti  tumor activity  of  the
LEAVES  OF  CASSIA FISTULA LINN was
determined  by  injecting DAL  cell  suspension
(1×106 cells per mouse) in to the peritoneal cavity of
the  animals  and  treatment was  started  after  24
hours  of  the  tumor inoculation  continued
once  daily  for  14  days  as described in the fig and
the  antitumor  efficacy  of LEAVES  OF  CASSIA
FISTULA LINN was compared with that of 5-Fu (10mg/kg, i.p) and DAL control.
3.7.2. DETERMINATION OF BODY WEIGHT AND SURVIVAL TIME 
Body weight analysis:
All the mice were weighed for every five days, after
tumor  inoculation.  Average  gain  in  body  weight  was
determined and recorded in table no and fig And a %decrease
in body weight were calculated by the formula.
%Decrease in body weight = (Decrease in body weight/initial body weight) ×100
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    DAL  induced ascitic tumor
3.7.3. Mean Survival Time (MST):
After induction every day checks all the groups for mortality & record how many
days the mouse is survived the mean survival time (MST) and  percentage increase in life span
(ILS %) was calculated by using the formula.
Mean survival time = [1st Death + Last Death] / 2
  ILS (%) = [(Mean survival of treated group/ Mean survival of
control group)-1] x100
3.8. DETERMINATION OF HEMATOLOGICAL & IN VIVO-ANTIOXIDANT
3.8.1. Determination of tumor volume:
After  14  days  treatment  the  mice  were  dissected  and  the  ascitic  fluid  was
collected  from  the  peritoneal  cavity.  The  volume  was  measured  by  taking  it  in  a
graduated centrifuge tube.
3.8.2. Viable and non-viable cell count:
Requirements:
a) Daltons lymphoma ascites (DLA) cells
b) Phosphate buffer saline solutions
c) Haemocytometer
d) Tryphan blue solution (0.4%)
Method:
After 14 days treatment animals are slightly anaesthetized with diethyl ether from
the intraperitoneal cavity of mice take 0.2ml of cell suspension were mixed with 0.5ml of
0.4% typhan blue, 0.3ml of normal saline or PBS and kept aside for 5min and not more
than 15min. From this one drop of solution was taken on a neubauer chamber and a cover
slip is placed.  This is  placed on Haemocytometer  and the viable and non-viable cells
were counted under 10X power Viable cells doesn’t take colour and these cells appear in
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white colour on blue background Non-viable cells(dead cells) take blue colour and give
dark blue shading to the cells, cell count was calculated using formula.
                      Cell count = No. of cells x Dilution factor × volume factor 
Preparation of Blood Serum and Tissue Samples For The Bio Chemical Studies:
 After 14 days treatment the animals were fasted over night and collect the blood
sample and intraperitoneal fluid by mild anaesthetized the mice with diethyl ether and
then sacrificed by cervical dislocation.
 Blood was collected for estimation of  RBC, WBC, Differential cell count , Hb
percentage and platelet count and serum was separated from blood cells by centrifugation
at about 2000 rpm for 30 min and this serum is used  for estimation of SGOT, SGPT,
serum creatinine, serum triglycerides, alkaline phosphatase, albumin, total protein values.
Tissues like liver and kidney were  removed from the mouse body and tissues
were  transferred  to  ice  cooled  containers.  Wiped  thoroughly  using  blotting  paper  to
remove blood and other body fluids then they were washed in normal saline, again wiped
desired  amounts  of  dried  tissues  were  used  for  various  biochemical  analysis  and
histopathology studies . 
3.8.3. Estimation of Hematological Parameters76-77:
A) 3.8.3.1.Enumeration of white blood cells:
The total white blood cells were enumerated according to the method of John (1972)
Reagents:
Turk’s fluid (WBC diluting fluid).
Procedure:
Using a white blood cell pipette of haemocytometer, well mixed blood was drawn up to
0.5 mark and WBC diluting fluid was taken up to mark II. The fluid blood mixture was
shaken and transferred onto the counting chamber. The cells were allowed to settle to the
bottom of the chamber for 2 min. See the fluid does not get dried.
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Using 10X or low power objective the WBC’s were counted uniformly in the
larger corner squares. 
The cells were expressed as number of cells x109/L
B) 3.8.3.2.Enumeration of red blood cells78:
Reagents: RBC diluting fluid s
Procedure:
Using a red blood cell pipette of haemocytometer, well mixed blood was drawn
up to 0.5 mark and RBC diluting fluid was taken up to mark II. The fluid blood mixture
was shaken and transferred onto the counting chamber. The cells were allowed to settle to
the bottom of the chamber for 2 min. See the fluid does not get dried. Using 45X or high
power objective the RBC’s were counted uniformly in the larger corner squares.  
The cells were expressed as number of cells x1012/Lorx 106 / cu.mm
C)  3.8.3.3.Differential Leukocyte Count78:
Differential Leukocyte count was determined by the method of John (1972).
Reagent:
Leishmann’s  stain:  150mg of  powdered  leishmann’s  stain  was dissolved in  133ml of
acetone free methanol.
Procedure:
A blood film stained with leishmann’s stain was examined under oil immersion
and the different types of WBCs were identified. The percentage distribution of these
cells was then determined. Smears were made from anticoagulant blood specimens and
stained with leishmann’s stain. The slides were preserved for counting the number of
lymphocytes and neutrophils, per 100 cells were noted. 
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The number of neutrophils was expressed as (%)
D) 3.8.3.4. Estimation of Hemoglobin:
Sahli’s acid haematin method79:
Principle:
Hemoglobin  is  converted  into  acid  haematin  by  the  action  of  HCl.  The  acid
haematin  solution is  further  diluted with distilled water  until  its  colour  matches with
exactly that of permanent standard of comparator block. The Hb concentration is read
directly from the calibration tube.
Requirements:
HCl solution, sahli’s Hemoglobinometer, pipette, distilled water.
Procedure:
       By using pipette add 0.1 N HCl in the Hemoglobinometer up to the lowest
marking. 20µl of blood was drawn up to 20µl in the sahli’s pipette. Adjusted the blood
column carefully without bubbles. Wiped the excess of blood on the sides of the pipette
by using a dry piece of cotton. Blown the blood into the acid solution in the graduated
tube, rinsed the pipette well. Mixed the reaction and allow the mixture to stand at room
temperature of 10 minutes. Diluted the solution with distilled water by adding few drops
of water carefully and by mixing the reaction mixture until the colour matches the colour
in the comparator. The lower meniscus of the fluid was noted and reading was noted in
g/100ml.79
3.9. ESTIMATION OF SERUM BIOCHEMICAL PARAMETERS:
SGOT,  SGPT was  estimated  using  whole  blood.  All  the  above  biochemical
parameters  were  estimated using semi-auto analyzer  (Photometer  5010  V5+,  Germany)
with enzymatic kits procured from Primal Healthcare limited, Lab Diagnostic Division,
Mumbai, India.) 
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3.9.1. ESTIMATION OF SGOT:
Serum   glutamate oxaloacetate transaminase (SGOT)80:
Principle:
Alanine aminotransferase (ALAT) and aspartate  amino transferase (ASAT) are
the most important of a group of enzymes of aminotransferase. These enzymes act as
catalyst in conversion of α-keto acids in to amino acids by transfer of amino groups.
Increased levels of  ALAT is found in the hepatobillary disease condition where
as increased ASAT levels occur in damaged conditions of heart and skeletal muscles well
as liver parenchyma. Parallel measurement of ALAT and ASAT is therefore applied to
distinguish liver from heart or skeletal muscle damages
The ASAT/ALAT ratio is used from differential diagnosis of liver diseases
    L-Aspartate + 2-Oxaloglutarate       ASAT     L-Glutamate + oxaloacetate
     Oxaloacetate + NADH + H⁺       MDH       D-  Malate + NAD⁺
Method:
Optimized  UV-  test  according  to  IFCC  (International  Federation  of  Clinical
Chemistry and Laboratory Medicine).
Table 3.5. Shows Reagents of SGOT in the kit
Reagent-1 concentration
TRIS      Ph 7.8 80 mmol/l
MDH (malatedehydrognase)240 mmol/l ≥600 U/l
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L- Aspartate
LDH(lactate dehydrogenase) ≥600 U/l
Reagent-2
2-Oxaloglutarate 12 mmol
NADH 0.18 mmol
Good buffer      pH   9.6 0.7 mmol/l
Pyridoxal-5-Phosphate 0.09 mmol/l
Assay procedure:
a) Mixed 800 µl of reagent-1 with 200 µl of reagent-2 in a 5 ml test tube.
b) To this, added 100 µl of serum.
c) Mixed well and took the reading immediately.
Normal range : <37u/l.
B)  3.9.2.  ESTIMATION  OF  SGPT:  Serum  glutamate  pyruvate  transaminase
(SGPT)81:
Principle:
   L-Alanine +2-oxoglutarate       ALAT      L-Glutamate + Pyruvate
  Pyruvate + NADH + H⁺                         D-Lactate + NAD⁺
Dilshad P, M. Pharm Thesis, 2014, JKKNCP, Komarapalayam.                                     Page 45
 Addition  of  pyridoxal-5-phosphate  (P-5-P)  stabilizes  the  transaminases  and
avoids falsely low values in samples containing insufficient endogenous P-5-P, eg. from
patients with myocardial infarction, liver diseases and intensive care patients.
Method:
Kinetic UV test,according to the international federation of clinical chemistry and
laboratory medicine (IFCC).
Table 3.6.Shows reagents of SGPT in the kit
Reagent-1 Concentration
TRIS            PH 7.5 100 mmol/l
L-Alanine 500 mmol/l
LDH (lactate dehydrogenase) ≥1200 U/l
Reagent-2 Concentration
2-Oxoglutarate 15mmol/l
NADH 0.18 mmol/l
Good’s buffer       PH  9.6 0.7mmol/l
Pyridoxal -5-Phosphate 0.09 mmol/l
Assay procedure:
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Mix 800 µl of reagent-1 with 200 µl of reagent -2 in a 5 ml test tube.
a) To this, added 100 µl of serum.
b) Mixed well and took the reading immediately.
Normal range: <41u/l.
3.10. IN VIVO ANTI OXIDANT STUDIES82
Preparation of tissue homogenate
The tissue were weighed and 10% tissue homogenate was prepared with 0.025 M
Tris  –HCl  buffer,  Ph  7.5.After  centrifugation  at  10,000  ×g  for  10  min,  the  clear
supernatant was used to measure thiobarbituric acid reactive substances(TBARS).
For the estimation of non-enzymic and enzymic antioxidants, tissue was minced
and homogenized (10% w/v) in 0.1 M phosphate buffer (Ph 7.0) and centrifuged for 10
min and the resulting supernatant was used for enzyme assays.
A) 3.10.1 Enzymatic antioxidant activity:-
I. 3.10.1.1.Estimation of Superoxide Dismutase (SOD) activity :-
Reagents:
1. Adrenaline
2. Carbonate buffer (pH10.2),
3. 0.1Mm EDTA
 The  activity  of  superoxide  dismutase  (SOD)  was  assayed  by  the  method  of
Kakkar et al based on the oxidation of epinephrine adrenochrome transition by enzyme.
The post-mitochondrial suspension of mice liver (0.5ml) was diluted with distilled water
(0.5). To this chilled ethanol (0.25ml) and chloroform (0.15ml) were added. The mixture
was shaken for 1 min and centrifuged at 2000  × g for 10 min.The PMS (0.5ml) was
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added  with  PBS  buffer  (Ph  7.2;  1.5ml).The  reaction  initiated  by  the  addition  of
epinephrine(0.4ml)  and  change  in  optical  density  (O.D.,min-1)  was  measured  at  470
nm.SOD  activity  was  expressed  as  U/mg  of  tissue.Change  in  O.D  (min-1)  at  50%
inhibition to adrenochrome transition by the enzyme was taken as one enzyme unit.
II. 3.10.1.2.Estimation of Catalase (CAT) activity:-83
Reagents:
1.  Dichromate/acetic acid reagent (5% solution of potassium dichromate in acetic
acid at     1:3 ratios)
2. 0.01 M Phosphate buffer, pH 7.0
3. 0.2 M Hydrogen peroxide
  Catalase(CAT)  was  estimated  by  the  method  of  Sinha  (1972).The  reaction
mixture (1.5ml vol) contained 1.0 ml of 0.01 M phosphate buffer (Ph7.0) 0.1 ml of tissue
homogenate and 0.4 ml of 2M H2O2. The reaction was stopped by the addition of 2.0 ml
dichromate-acetic acid reagent (5% potassium dichromate and glacial  acetic acid  were
mixed in 1:3 ratio).Then thebabsorbance was measured at  530 nm; CAT activity was
expressed as µM of H2O2 consumed/min/mg protein
III. 3.10.1.3. Estimation of Glutathione peroxidase (GPx) activity:-84
Reagents:
1. 0.32 M Phosphate buffer, pH 7.0
2.  0.8 mM EDTA
3. 10 mM Sodium azide
4. 3 mM reduced glutathione
5. 2.5 mM H2O2
6. 10% TCA
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7. 0.3 M Disodium hydrogen phosphate
8. DTNB solution (40 mg of DTNB in 100 ml of 1% sodium citrate)
Procedure:
Glutathione peroxidase (GPx) was measured by the method described by Rotruck
et al.(1973).Briefly,  the reaction mixture contained 0.2 ml 0.4 M phosphate buffer (Ph
7.0),0.1  ml  10m  M  sodium  azide,0.2  ml  tissue  homogenized  in  0.4  M  ,phosphate
buffer,Ph  7.0,0.2  ml  tissue  homogenized  in  0.4  M,phosphate  buffer  ,Ph  7.0,0.2  ml
reduced glutathione ,and 0.1 ml 0.2 mM hydrogen peroxide. The contents were incubated
for 10 min at 37 ⁰c,0.4 ml 10% TCA was added to stop the reaction and centrifuged at
3200 × g for 20 min.The supernatant was assayed for glutathione content using Ellman’s
reagent  (19.8  mg  5,5’-dithiobisnitrobenzoic  acid  (DTNB)  in  100  ml  0.1%  sodium
nitrate). The activities were expressed as µg of GSH consumed/ min/mg protein. 
B) 3.10.2. Non enzymatic anti oxidant activity
I. 3.10.2.1. Estimation of reduced glutathione(GSH) activity:-85
Reagents:
1. 10% TCA
2. 0.6 mM 5,5’-dithiobis-2-nitrobenzoic acid (DTNB) in 0.2 M sodium phosphate
3. 0.2 M Phosphate buffer, pH 8.0
     Reduced glutathione (GSH)  was measured by the method of Ellman (1959).The PMS
of rat liver (720 µl) and 5% TCA were mixed to precipitate the protein content of the
supernatant.After  centrifugation  at  10,000  ×  g  for  5  min,  the  supernatant  was  taken.
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DTNB (5,5’-dithio-bis(2-nitrobenzoic acid ) Ellman’s reagent was added to it  and the
absorbance  was  measured  at  412  nm.  A  standard  graph  was  drawn  using  different
concentration of standard GSH solution.GSH contents were calculated in the PMS of rat
liver.
II. 3.10.2.2. Estimation of Lipid Peroxidation of Rat Liver and Kidneys86
Reagents: 
1. Thiobarbituric acid 0.37%
2.  0.25 N HCl
      3 . 15% TCA
Lipid  peroxidation  in  liver  and  kidney  was  estimated  calorimetrically  by
measuring thiobarbituric acid reactive substances (TBARS) using the method of Fraga et
al.(1988).  In  brief,0.1  ml  of  tissue  homogenate  was  treated  with  2  ml  of  TBA-
trichloroacetic acid –HCl reagent (0.37% TBA,0.25 M HCl and 15% TCA, 1:1:1 ratio),
placed for 15 min in a water bath and then cooled and centrifuged at 3500 ×g for 10 min
at   room temperature,  the  absorbance  of  clear  supernatant  was  measured  at  535  nm
against a reference blank. Values were expressed as Mm/100 g tissue.
C) 3.10.2.3.  Estimation of proteins87
Principle
Procedure described by Lowery et al(1951) was used for protein estimation. The
method  is  based  on  the  biuret  reaction,  formation  of  a  protein-copper  complex  and
reduction  of  phosphor molybdo  tungstate  reagent  (Folin-ciocalteu  phenol  reagent)  by
tyrosine and tryptophan residues of protein to form a coloured product.
Reagents:
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Solution A: 1ml CuSO4 5H2O (1%) + 1ml sodium potassium tarterate (2%) + 98
ml 2% Na2CO3 in 0.1N NaOH.
Solution B: Folin Ciocalteu reagent  and distilled water mixed in 1:1 ratio just
before use.
Procedure:
 0.01 ml of tissue homogenate (2.5%) was diluted to 1.2 ml and mixed with 6 ml
of solution A. The mixtures was incubated at room temperature for 10 min and add 0.3
ml solution B was added, mixed immediately and kept at room temperature for 30 min.
optical  density was taken at  750 nm. The amount of protein was calculated from the
standard curve of bovine serum albumin (BSA).
D) 3.10.2.4. Estimation of ascorbic acid vitamin C88
The level of ascorbic acid was estimated by the method of Omaye et al.1979).
Reagents
1. 5% TCA
2. DTC reagent 3 g of 2,4-dinitrophenyl hydrazine, 0.4 g of thiourea and 0.05 g
of copper sulphate were dissolved in 100 ml of 9 N sulphuric acid)
3. 65% sulphuric acid
4. Ascorbic acid
Procedure
To 0.5 ml of homogenate, 0.5 ml of water and 1 ml of TCA were added, mixed
thoroughly and centrifuged. To 1 ml of the supernatant, 0.2 ml of DTC reagent was added
and incubated at 37°C for 3 hrs. Then 1.5 ml of sulphuric acid was added, mixed well and
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the solutions were allowed to stand at room temperature for another 30 min. The colour
developed was read at 520 nm.
The level of ascorbic acid was expressed as µg/mg protein
E) 3.10.2.5. Estimation of vitamin E88
The level of vitamin E was estimated by the method of Desai 1984).
Reagents
1. Ethanol
2. Petroleum ether
3. 0.2% 4,6-diphenyl-1,10-phenanthroline in ethanol
4. 0.001 M Ferric chloride in ethanol
5. 0.001 M o-phosphoric acid in ethanol
6. α-Tocopherol acetate
Procedure
To 1 ml of homogenate, 1 ml of ethanol was added and thoroughly mixed. Then 3
ml of petroleum ether was added, shaken rapidly and centrifuged. 2 ml of supernatant was
taken and evaporated to dryness. To this 0.2 ml of bathophenanthroline was added. The
assay mixture was protected from light and 0.2 ml of ferric chloride was added followed by
0.2 ml of o-phosphoric acid. The total volume was made up to 3 ml with ethanol. The colour
developed was read at 530 nm.
The level of vitamin E was expressed as µg/mg protein.
3.11. HISTOPHATOLOGICAL TECHINIQUES: 
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Histopathology is the microscopical study of tissues for pathological alterations.
This involves collection of morbid tissues from biopsy or necropsy, fixation, preparation
of sections, staining and microscopical examination.
Collection of materials:
         Thin pieces of 3 to 5 mm, thickness are collected from tissues showing gross
morbid changes along with normal tissue.
Fixation:
 Keeping the tissue in Fixative for 24-48 hours at room temperature
a) Serves to harden the tissues by coagulating the cell protein,
b) Prevents autolysis,
c) Preserves the structure of the tissue, and 
d) Prevents shrinkage: The volume of the fixative added is 10times the volume of the
tissues.
Common Fixatives:10% Formalin.   
Haematoxylin and eosin method of staining:
Deparaffinise the section by xylol 5 to 10 minutes and remove xylol by absolute
alcohol, then wash in tap water. Stain with haematoxylin for 3-4 minutes and wash in tap
water. Allow  the sections in tap water 5-10 min and wash in  tap water. Counter stain
with 0.5% until section appears light pink(15 to 30seconds ),  then wash in tap water.
Blot and dehydrate in alcohol. Clear with xylol (15 to 30 seconds). Mount in  Canada
balsam or DPX Moutant. Keep slide dry and remove air bubbles.
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4. RESULTS 
Phytochemical studies of Methanolic extracts of leaves of Cassia fistula linn.
4.1.1 Preliminary Phytochemical Tests
Table 4.1 Shows preliminary qualitative chemical tests of Cassia fistula linn
S.N. Phytochemical constituents
Cassia fistula
linn
1. Carbohydrates +ve
2. Alkaloids +ve
3. Steroids & sterols +ve
4. Glycosides +ve
5. Saponins +ve
6. Flavonoids +ve
7. Tannins & phenolic compound +ve
8. Proteins & amino acids -ve
4.2. INVITRO ANTI OXIDANT STUDY
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4.2.1. DETERMINED BY MTT ASSAY AGAINST HELA CELL LINES:
Table 4.2. Shows of the Toxicity in Cassia fistula determined by MTT assay against
HELA cell lines
Groups Concentration Percentage Toxicity
DMSO 7.90 ± 0.20
Standard 25 mg/ml 15.50 ± 0.53**
50 mg/ml 12.33 ± 0.42**
100 mg/ml 14.27 ± 0.17**
Cassia fistula 25 mg/ml 11.90 ± 0.40**
50 mg/ml 13.60 ± 0.20**
100 mg/ml 11.07 ± 0.17**
Values are expressed as mean ± SEM. **p<0.01 vs DMSO (Oneway ANOVA 
followed by Dunnett’s test)
4.2.2. TRYPHAN BLUE DYE EXCLUSION TEST
Table 4.3. Shows of the Viability of Hela cell lines by Cassia fistula determined on
Tryphan Blue Exclusion test
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Concentration % Viability % Toxicity
DMSO 95.23 4.76
Cassia fistula 100 mg/ml 86.36 13.6
Standard 100 mg/ml 95 5
4.3. INVITRO ANTI OXIDANT STUDY
4.3.1. DPPH Radical Scavenging Activity:
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Table 4 .4. Shows % inhibition of DPPH radical scavenging activity of
Methanolic extracts of leaves  of Cassia fistula linn.
CONTROL: 0.4335
Serial
number
Concentration
(µg/ml)
% of activity
Cassia fistula Standard
MEAN SEM MEAN SEM
1 20.000 19.37563 0.3221953 28.44137 0.322195
2 40.000 39.62937 1.146634 32.33987 1.146635
3 60.000 42.69743 0.9489966 36.69973 0.9489955
4 80.000 51.72472 0.8438241 56.8689 0.8438246
5 100.000 60.09842 1.103273 69.09496 1.103276
IC50 =71.29 IC50 =66.26
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4.3.2 ABTS: Radical Scavenging Activity:
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Table4.5. Shows % inhibition of  ABTS  radical scavenging activity of
Methanolic extracts of leaves  of Cassia fistula linn.
CONTROL: 0.8615
Serial
number
Concentration
(µg/ml)
% of activity
Cassia fistula Standard
MEAN SEM MEAN SEM
1 20.000
24.94409 0.1621264
23.3925
3 0.1410932
2 40.000
29.355 0.5769777
36.2925
1 0.442966
3 60.000
42.77346 0.4775271
49.7419
2 0.5913936
4 80.000
51.11163 0.4246065
62.0073
5 0.4365487
5 100.000 57.24047 0.5551583 74.9615 0.3762644
IC50 =79.05 IC50 =54.99
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4.3.3 TRAP: Radical Scavenging Activity:
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Table4.6. Shows % inhibition of  TRAP radical scavenging activity of
Methanolic extracts of leaves  of Cassia fistula linn.
CONTROL: 0.9615
Serial
number
Concentration
(µg/ml)
% of activity
Cassia fistula Standard
MEAN SEM MEAN SEM
1 20.000
75.04178 0.1264189
51.2837
6 0.1452642
2 40.000
67.23453 0.3968955
48.4548
5 0.5169694
3 60.000 58.1099 0.5298852 42.3498 0.427863
4 80.000
46.24996 0.3911458
24.7141
6 0.3804448
5 100.000
35.94315 0.3371318
21.6876
4 0.4974199
IC50 =69.28 IC50 =27.40
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4.3.4 FRAP: Radical Scavenging Activity:
Table4.7. Shows % inhibition of  FRAP radical scavenging activity of
Methanolic extracts of leaves  of Cassia fistula linn.
Sample Concentration Absorbance
Cassia fistula 10 0.9154 0.9122 0.9126
20 1.0554 1.0526 1.0548
30 1.2274 1.2268 1.2237
40 1.3145 1.3124 1.3187
50 1.3684 1.3626 1.3625
Standard 0.1 0.1214 0.1216 0.1212
0.2 0.3041 0.3045 0.3037
0.4 0.4586 0.4592 0.4580
0.6 0.5955 0.5957 0.5956
0.8 0.7243 0.7250 0.7236
1.0 0.8476 0.8482 0.8479
Concentration Absorbance (mean ± SEM)
10 0.9134 0.001006662
20 1.0543 0.0008511411
30 1.2260 0.001146461
40 1.3152 0.001852018
50 1.3645 0.00195022
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Extract 1 
50µg of extract is equivalent to 4.56 µg of standard
10.97 mg of Extract is equivalent to 1 mg of Standard
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4.4.  DAL INDUCED ACITIC TUMOR:
4.4.1. BODY WEIGHT ANALYSIS:
Effect of Methanolic extract of Leaves of Cassia fistula linn on body weight of
mice challenged with Daltons lymphoma ascetic cells.
Table 4.8. Shows body weight of various groups for every 10 days
EXPERIMEN
TAL GROUPS
Body weight (gm) Decreas
e in
body
weight
from
11th day
to 20th
day(gm)
%decrease
in body
weight0 day 11
th
 day 20th day
DAL
CONTROL
21.50±0.42
8
26.500±0.61
91
31.16667±0.
70
----------
--
---------------
---
DAL+STD
21.50±0.42
8
27.33333±0.
49
18.83333±0.
60
8.5 39.53
DAL+DOSE-I
21.67±0.66
6
26.66667±0.
66
21.83333±0.
65
4.8 22.22
DAL+DOSE-II
21.67±0.42
1
27.16667±0.
60
21.000±0.85
63
6.1 28.46
Values are expressed as the Mean ± S.E.M., (n = 6) on day 14 of the experiment;
Statistical  significance  (p)  calculated  by  one  way  ANOVA  followed  by  Dunnett’s
aP<0.01 calculated by comparing treated group with 5- fu standard group.
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BODY WEIGHT ANALYSIS
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EFFECT OF METHANOLIC EXTRACTS OF LEAVES OF Cassia fistula linn
ON BODY WEIGHT ANALYSIS
                                                  
ONLY VEHICLE                                                    ONLY DAL
                                     
DAL + 5 FLUROURACIL 20mg/kg                DAL + CASSIA FISTULA 250mg/kg  
DAL + CASSIA FISTULA 500mg/kg    
Dilshad P, M. Pharm Thesis, 2014, JKKNCP, Komarapalayam.                                     Page 64
4.4.2. MEAN SURVIVAL TIME (MST) :
Effect of Methanolic extract of Leaves of Cassia fistula linn on survival time
of mice challenged with Daltons lymphoma ascetic cells.
Table 4.9.Shows   mean survival time and percentage increase in life span various group
Experimental groups Mean survival time in days %ILS
DAL CONTROL 21.50±0.43 -
DAL+STD 42.50±0.76a 97.674
DAL+DOSE-I 30.33333±1.021981a 41.0853
DAL+DOSE-II 34.16667±1.922094a 58.9147
Values are expressed as the mean ± S.E.M.; Statistical significance (p) calculated
by one way ANOVA  followed by dunnett’s aP< 0.05 , NS – non significant calculated by
comparing treated group with DAL control group. 
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4.5. EFFECT ON TUMOR PACKED CELL VOLUME   and   TUMOR VOLUME  
on Methanolic extracts of leaves of Cassia fistula linn 
Table 4.10.  Shows tumor volume of experimental groups.
Test CONTROL DAL_Dose_I DAL_Dose_II DAL_STD ONLY_DAL
TUMOR
PACKED
VOLUME
0.00±0.00a 7.10±0.890 5.48±1.025 5.17±1.508 6.97±2.368
TUMOR
VOLUME
0.00±0.00a 20.67±5.785 14.67±3.266a 10.00±4.64a 22.83±4.401
Values are expressed as the mean ± S.E.M.; Statistical significance (p) calculated
by one way ANOVA  followed by Dunnett’s aP< 0.05 , NS – non significant calculated
by comparing treated group with DAL control group. 
Dilshad P, M. Pharm Thesis, 2014, JKKNCP, Komarapalayam.                                     Page 66
4.6. EFFECT OF METHANOLIC EXTRACTS OF LEAVES OF Cassia fistula linn
ON VIABLE AND NON-VIABLE CELL COUNT
Table 4.11.Shows VIABLE AND NON-VIABLE CELL COUNT
EXPERIMENTAL 
GROUPS
DAL 
CONTROL
DAL+ST
D
DAL+Dose-I DAL+Dose-II
Viable cell count 9.77±0.17
2.28±0.07
a
4.583333±0.2
166667a
4.033333±0.431
22a
Non-viable cell 
count
0.84±0.10
5.75±0.07
a
4.783333±0.1
973435a
3.683333±0.267
6025a
Values are expressed as the mean ± S.E.M., (n = 6) on day 14 of the experiment;
Statistical significance (p) calculated by one way ANOVA  followed by Dunnett’s  aP<
0.05 , NS – non significant calculated by comparing treated group with DAL control
group.            
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   DAL + Cassia fistula 250mg/kg                                 DAL + Cassia fistula 500mg/kg 
4.7. Effect of Methanolic extract of Leaves of Cassia fistula linn on 
hematological parameters in   mice challenged with Daltons lymphoma ascetic cells.
Test Units CONTROL
DAL Dos
_I DAL Dos II DAL+STD
ONLY
DAL
ESONOPHIL % 2.00±0.632a 5.83±2.137 5.50±0.548 3.67±1.633a 7.00±1.414
HB gdl 14.97±074a 13.28±0.71
a
11.35±0.979 13.04±1.447
a
10.65±1.063
LYMPHOCYTE % 93.33±2.53a 84.33±4.74
a
87.33±1.751a 84.83±2.639
a
74.83±4.119
MCH Pictogra
mscell
16.90±1.81a 14.85±2.19
a
15.05±1.475a 16.25±2.130
a
21.37±2.002
MONOCYTE % 3.17±1.169a 7.67±2.944 4.50±1.378a 4.83±1.722a 10.33±2.160
NEUTROPHIL % 1.33±0.516a 2.17±1.472
a
2.50±0.837a 6.67±2.160 8.17±2.714
PCV % 50.25±1.58a 40.20±5.81
a
37.75±3.109a 42.53±2.982
a
30.40±4.769
Dilshad P, M. Pharm Thesis, 2014, JKKNCP, Komarapalayam.                                     Page 69
Test Units CONTROL
DAL Dos
_I DAL Dos II DAL+STD
ONLY
DAL
RBC 1*10000
00MM3
9.19±0.349a 7.74±0.640
a
7.42±0.681a 7.50±0.753a 5.14±0.687
WBC 1*1000
MM3
16.21±8.38a 21.47±5.90
a
22.82±9.53a 23.27±11.02
a
38.83±5.695
Values are expressed as the mean ± S.E.M., (n = 6) on day 13 of the experiment; aP<0.05,
BP<0.01,  and  CP<0.001  between  normal  and  tumor  control aP<0.05,  BP<0.01,  and
CP<0.001 between normal and tumor control and treated groups and ns - non significant.
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Figure ; RBC, WBC, HB,  PCV,  NEUTROPHIL, ESONOPHIL,  LYMPHOCYTE
MONOCYTE MCH.
4.8. Effect of Methanolic extract of Leaves of Cassia fistula linn serum 
biochemical parameters in   mice challenged with Daltons lymphoma ascetic cells.
ALKALINE PHOSPHATASE (ALP):
Table 4.12.Shows  Serum in ALP levels.
Test Unit
s
CONTROL DAL +DOSE-
I
DAL + 
DOSE-II
DAL + STD ONLY DAL
AL
P
u/l 223.00±47.9
a
165.83±31.70
8a
27.87±5.41
5
342.00±35.54
2a
58.50±15.66
8
Values are expressed as the mean ± S.E.M., (n = 6) on day 14 of the experiment;
aP<0.05, bP<0.01, and cP<0.001 between normal and tumor control dP<0.05, eP<0.01, and
fP<0.001 between tumor control and treated groups and ns- non significant.                 
  ALKALINE PHOSPHATASE (ALP)
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4.9. SERUM GLUTAMATE OXALOACETATE TRANSAMINASE (SGOT):
Table 4.13.Shows Serum in SGOT levels.
Test Unit
s
CONTROL DAL 
+DOSE-I
DAL + 
DOSE-II
DAL + STD ONLY DAL
SGO
T
u/l 149.50±31.3
48
94.33±4.66
a
225.17±2.31
7a
122.83±9.06
5
147.33±19.22
2
Values are expressed as the mean ± S.E.M., (n = 6) on day 14 of the experiment;
aP<0.05, bP<0.01, and cP<0.001 between normal and tumor control dP<0.05, eP<0.01, and
fP<0.001 between tumor control and treated groups and ns - non significant.
GLUTAMATE OXALOACETATE TRANSAMINASE (SGOT)
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4.10. SERUM GLUTAMATE PYRUVATE TRANSAMINASE (SGPT):
Table 4.14:Shows Serum in SGPT levels.
Test Units CONTROL DAL
+
DOSE-I
DAL 
+ 
DOSE-II
DAL + STD ONLY DAL
SGPT u/l 85.75±10.36a 49.67±4.59 34.52±1.059a 47.27±1.106a 59.35±10.706
Values are expressed as the mean ± S.E.M., (n = 6) on day 14 of the experiment;
aP<0.05, bP<0.01, and cP<0.001 between normal and tumor control dP<0.05, eP<0.01, and
fP<0.001 between tumor control and treated groups and ns- non significant.
GLUTAMATE PYRUVATE TRANSAMINASE (SGPT)
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4.11. SERUM IN CHOLESTEROL:
Table 4.15:  Shows Serum in CHOLESTEROL levels
Test Units CONTROL DAL+DOSE
-I
DAL + DOSE-
II
DAL + STD ONLY
DAL
Cholesterol mgdl 81.00±4.43 83.17±13.96 150.33±26.82a 118.50±52.8a 67.67±6.861
Values are expressed as the mean ± S.E.M., (n = 6) on day 14 of the experiment;
aP<0.05, bP<0.01, and cP<0.001 between normal and tumor control dP<0.05, eP<0.01, and
fP<0.001 between tumor control and treated groups and ns- non significant.
CHOLESTEROL
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4.12. SERUM IN TRIGLYCERIDES (TGL):
Table 4.16 Shows Serum in TGL levels
Test Units CONTROL DAL+DOSE-I DAL+DOSE-II DAL + STD ONLY DAL
TGL mgdl 76.15±17.55a 71.22±16.75a 466.00±45.374 80.97±11.20a 438.83±49.44
Values are expressed as the mean ± S.E.M., (n = 6) on day 14 of the experiment;
aP<0.05, bP<0.01, and cP<0.001 between normal and tumor control dP<0.05, eP<0.01, and
fP<0.001 between tumor control and treated groups and ns- non significant.
TRIGLYCERIDES (TGL):
Dilshad P, M. Pharm Thesis, 2014, JKKNCP, Komarapalayam.                                     Page 75
4.13. SERUM IN HDL:
Table 4.17:  Shows Serum in HDL levels
Test Units CONTROL DAL+DOSE-I DAL+DOSE-II DAL + STD ONLY DAL
HDL gdl 78.93±12.93 62.48±2.47a 57.53±3.449a 65.8±14.41a 113.95±55.18
Values are expressed as the mean ± S.E.M., (n = 6) on day 14 of the experiment;
aP<0.05, bP<0.01, and cP<0.001 between normal and tumor control dP<0.05, eP<0.01, and
fP<0.001 between tumor control and treated groups and ns- non significant.
SERUM IN HDL
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4.14. EFFECT OF METHANOLIC EXTRACT OF LEAVES OF CASSIA
FISTULA LINN ON IN VIVO ANTIOXIDANT STUDIES IN   MICE
CHALLENGED WITH DALTONS LYMPHOMA ASCETIC CELLS.
ENZYMATIC ANTI – OXIDANT ACTIVITY
4.14.1. ESTIMATION OF SUPEROXIDE DISMUTASE (SOD) ACTIVITY:
Table 4.18:  Shows SOD level.
Test Units CONTROL DAL 
+DOSE-I
DAL + 
DOSE-II
DAL +
STD
ONLY
DAL
SO
D
Units/m
g of 
tissue
9.27±0.520
a
9.59±0.795
a
11.50±0.508
a
8.98±0.701
a
4.90±0.326
Values are expressed as the mean ± S.E.M., (n = 6) on day 14 of the experiment;
aP<0.05, bP<0.01, and cP<0.001 between normal and tumor control dP<0.05, eP<0.01, and
fP<0.001 between tumor control and treated groups and ns- non significant.
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EFFECT OF LEAVES OF CASSIA FISTULA LINN ON SOD
4.14.2. ESTIMATION OF CATALASE ACTIVITY:
Table 4.19: Shows Catalase level.
Test Units CONTROL DAL
+DOSE-I
DAL +
DOSE-II
DAL + STD ONLY
DAL
CAT µm H2O2 
consumedg
of tissue
56.79±3.510a 70.16±1.738a 46.92±3.039 88.17±1.795a 42.05±5.116
Values are expressed as the mean ± S.E.M., (n = 6) on day 14 of the experiment;
aP<0.05, bP<0.01, and cP<0.001 between normal and tumor control dP<0.05, eP<0.01, and
fP<0.001 between tumor control and treated groups and ns- non significant.
EFFECT OF LEAVES OF CASSIA FISTULA LINN ON CATALASE
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4.14.3. ESTIMATION OF GLUTATHIONE PEROXIDASE (GPX) ACTIVITY :
Table 4.20.Shows GPX level of serum.
Test Units CONTROL DAL
+DOSE-I
DAL +
DOSE-II
DAL + STD ONLY
DAL
GPX Moles of 
glutathione 
oxidizedg 
protein
0.87±0.011a 0.63±0.054a 2.09±0.110a 3.57±0.044a 4.79±0.131
Values are expressed as the mean ± S.E.M., (n = 6) on day 14 of the experiment;
aP<0.05, bP<0.01, and cP<0.001 between normal and tumor control dP<0.05, eP<0.01, and
fP<0.001 between tumor control and treated groups and ns- non significant.
GLUTATHIONE PEROXIDASE (GPX)]
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NON-ENZYMATIC ANTIOXIDANT ACTIVITY
4.14.4. ESTIMATION OF REDUCED GLUTATHIONE (GSH) ACTIVITY:
Table4.21 Shows GSH level of serum.
Test Units CONTROL DAL 
+DOSE-I
DAL + 
DOSE-II
DAL + STD ONLY
DAL
GSH mg of 
GSHg of 
tissue
0.32±0.195a 0.65±0.095 0.77±0.082a 0.85±0.077a 0.51±0.082
Values are expressed as the mean ± S.E.M., (n = 6) on day 14 of the experiment;
aP<0.05, bP<0.01, and cP<0.001 between normal and tumor control dP<0.05, eP<0.01, and
fP<0.001 between tumor control and treated groups and ns- non significant.
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  REDUCED GLUTATHIONE (GSH)
4.14.5. ESTIMATION OF LIPID PEROXIDATION (LPO) ACTIVITY:
Table4.22 Shows GSH level of serum.
Test Units CONTROL DAL
+DOSE-I
DAL +
DOSE-II
DAL + STD ONLY
DAL
LPO mm of 
MDA 
releasedg 
of protein
0.84±0.109 0.44±0.015a 0.53±0.040a 0.67±0.095a 0.79±0.060
Values are expressed as the mean ± S.E.M., (n = 6) on day 14 of the experiment;
aP<0.05, bP<0.01, and cP<0.001 between normal and tumor control dP<0.05, eP<0.01, and
fP<0.001 between tumor control and treated groups and ns- non significant.
LIPID PEROXIDATION (LPO)
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4.14.6. ESTIMATION OF TOTAL PROTEIN:
Table4.23 Shows PROTEIN level in serum.
Test Units CONTROL DAL
+DOSE-I
DAL +
DOSE-II
DAL +
STD
ONLY
DAL
TOTAL 
PROTEIN
1.25±0.123a 2.00±0.143a 2.32±0.092a 1.39±0.081a 2.58±0.087
Values are expressed as the mean ± S.E.M., (n = 6) on day 14 of the experiment;
aP<0.05, bP<0.01, and cP<0.001 between normal and tumor control dP<0.05, eP<0.01, and
fP<0.001 between tumor control and treated groups and ns- non significant.
TOTAL PROTEIN
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4.14.7. ESTIMATION OF ASCORBIC ACID (VIT.C):
Table4.24 Shows VIT.C level in serum.
Test Units CONTROL DAL
+DOSE-I
DAL +
DOSE-II
DAL + STD ONLY DAL
VIT.C Units
g of 
tissue
28.99±3.448a 68.09±5.486 84.95±43.337 86.14±16.187 69.83±0.915
Values are expressed as the mean ± S.E.M., (n = 6) on day 14 of the experiment;
aP<0.05, bP<0.01, and cP<0.001 between normal and tumor control dP<0.05, eP<0.01, and
fP<0.001 between tumor control and treated groups and ns- non significant.
ASCORBIC ACID
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4.14.8. ESTIMATION OF VIT.E (α-TOCHOPHREOL):
Table 4.25 Shows VIT.E level in Serum.
Test Units CONTROL DAL
+DOSE-I
DAL +
DOSE-II
DAL + STD ONLY
DAL
VIT.E Units g 
of tissue
0.35±0.010a 0.38±0.021a 0.43±0.034a 0.40±0.012a 0.18±0.009
Values are expressed as the mean ± S.E.M., (n = 6) on day 14 of the experiment;
aP<0.05, bP<0.01, and cP<0.001 between normal and tumor control dP<0.05, eP<0.01, and
fP<0.001 between tumor control and treated groups and ns- non significant.
α-TOCHOPHREOL 
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EFFECT OF METHANOLIC EXTRACT OF LEAVES OF CASSIA FISTULA
LINN ON HISTOPATHOLOGICAL ANALYSIS IN   MICE CHALLENGED
WITH DALTONS LYMPHOMA ASCETIC CELLS.
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Figure 4.3: Histology of liver stained with Haematoxylin-Eosin (×100) of mice from the
different groups, on day 14 of the experiment (n = 6): I: Normal; II:  DAL control; III:
DAL + 5-FU,20 mg/kg body weight; IV: DAL + CF250 mg/kg bodyweight; e: DAL +
5. DISCUSSION
The preliminary phytochemical studies of leaves of Cassia fistula linn indicated the
presence of several triterpenoids, phenols, flavonoids, tannins, glycosides, and so on. The
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observed  antitumor,  hepatoprotective,  and  antioxidant  activities  may  be  due  to  the
presence of any of these compounds in leaves of Cassia fistula linn.
Bioactive antioxidant levels:  
Flavonoids are a group of effective antioxidants which are present abundantly
throughout  the  plant  kingdom.  Flavonoid  and  related  compound  are  effective  in
scavenging DPPH radical, hydroxyl radical and in metal-chelating capacity  Flavonoids
are found to exhibit  numerous biological  activities like vasodilatory,  anticarcinogenic,
antiinflammatory,  antibacterial,  immune-stimulating,  antiallergic,  and  antiviral  effects
(Middleton &Kandaswami, 1992)14,15.
Tannins,  the high molecular  weight  phenols,  act  as  a  good  scavenger  of  free
radical either by donating hydrogen atom or by reducing them. This property is attributed
by the molecular weight, the number of aromatic rings and nature of hydroxyl group’s
substitution and specific functional groups present in the tannins. The results show that
the methanol extract contains more tannin.55
Phenols are very important plant constituents because of their radical scavenging
ability  due  to  the  hydroxyl  groups.  Polyphenols are  known  to  exhibit  a  variety  of
biological  actions  such  as  free  radicals  scavenging,  metal  chelation,  modulation  of
enzyme  activity  and  more  recently  to  effect  signal  transduction,  activation  of
transcription factors and gene expression.56
 Free  radicals  may be  defined  as  any  species  that  is  capable  of  independent
existence and possessing one or more unpaired electrons. These radicals can react with
other molecules in many ways. The net effect is that radical donates its unpaired electron
to another molecule and this molecule then becomes radical. 
The DPPH assay method is based on the reduction of DPPH, a stable free radical.
The free radical  DPPH with an odd electron gives  a maximum absorption at 517 nm
(purple colour). As the odd electron of the radical becomes paired off in the presence of a
hydrogen  donor,  e.g.,  a  free radical-scavenging antioxidant,  the absorption strength is
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decreased and results in decolorization (yellow colour)  with respect  to the number of
electrons captured57More the decolorization more is the reducing ability.  This test has
been the most accepted model for evaluating the free radical scavenging activity of any
new drug. The percent DPPH scavenging activities of leaves of cassia fistula linn extracts
was  summarised  in  (PAGE.).  The  scavenging  activity  (EC50) was  found  to  be
44.52µg/ml
ABTS The  decolorization of  ABTS•+cation  radical  is  an  unambiguous  way to
measure the antioxidant activity of phenolic compounds. Thus the ability of a compound
to  scavenge  ABTS•+ radical  can  demonstrate  oxygen  radical  absorbance  capacity.
Methanol extracts of A. pavonina showed very potent ABTS radical scavenging activity
(EC50) was found to be  17.46 µg/ml.
FRAP  assay  measures  the  reducing  ability  of antioxidants  against  oxidative
effects  of  reactive oxygen species. Electron donating anti-oxidants can be described as
reductants and  inactivation of oxidants by reductants  can  be  described  as  redox
reactions.  Total antioxidant power may be referred analogously to total reducing power.
In  the current  study    methanol extracts  of  A.  pavonina exhibited about 7.17 µg of
standard is equivalent  to 50 µg of leaves of cassia fistula linn extract  (143.4 mg/g of
extract).
TRAP, Methanol  extracts  of  A.  pavonina  showed  very  potent   radical
scavenging    activity (EC50) was found to be 62.95µg/ml.
Methanolic extract of Leaves of Cassia fistula linn   was traditionally used in
the  treatment  of  tumors.  The  present  investigation  was  carried  out  to  evaluate  the
antitumor activity of the leaves of  Cassia fistula linn in DAL tumor bearing mice. The
reliable criteria for judging the value of an anticancer drug is the prolongation of the life
span of animals. In DAL-tumor-bearing mice, a regular rapid increase in ascitic tumor
volume was observed62.  The DAL-bearing mice orally administered  leaves  of  Cassia
fistula linn at 250 and 500 mg/kg body weight showed significant change in the average
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life  span  compared  to  animals  of  the  tumor  control  group.  However,  the  percentage
increase in body weight, tumor cell volume, and number of viable tumor cells were found
to be significantly less than the tumor control animals, indicating the anticancer nature of
the  extract.  These  results  could  indicate  either  a  direct  cytotoxic  effect  of  leaves  of
Cassia fistula linn on tumor cells as evidenced by the in vitro studies or an indirect local
effect, which may involve macrophage activation and vascular permeability inhibition.
Hence, the observed antitumor nature of leaves of Cassia fistula linn may be due to the
cytotoxic properties. 
To investigate if  the inhibitory effect  of leaves of  Cassia fistula linn on DAL
tumor was local or systemic, the effect of i.p. injection of leaves of Cassia fistula linn in
another experimental system, DAL-induced solid tumor, was tested. The solid tumor was
inhibited by treatment with leaves of  Cassia fistula linn, suggesting that the inhibitory
effect is related not only to a local cytotoxic effect but also with the systemic effect of
leaves of Cassia fistula linn. 
The reversal of Hgb content, RBC, Total WBC, and differential count of WBC by
the leaves of Cassia fistula linn treatment towards the values of the normal group clearly
indicates  that  leaves  of  Cassia  fistula  linn possessed  protective  action  on  the
haemopoietic system. However, the elevation of WBC levels may be due to its adverse
effect on the haemopoietic system58.
It was reported that the presence of tumors in the human body or in experimental
animals is  known to affect  many functions of  the liver  and kidney.  The significantly
elevated levels of ALP, TB, and decreases in the levels of SOD in serum, liver, or kidney
of tumor-inoculated animals indicated liver damage and loss of functional integrity of cell
membranes59 . This was also indicated by the significant increase in the levels of ASAT,
ALAT, CR, and albumin and decreases in TGL, TP, TC, and CAT in the liver and kidney
tissues of the tumor control group. The significant reversal of these changes towards the
normal by leaves of cassia fistula linn treatment in most of the cases demonstrated the
potent hepato protective and antioxidant nature of leaves of Cassia fistula linn.
 The antioxidant nature of leaves of Cassia fistula linn was also evident by the in
vitro  studies.  Plants  with  high  total  phenol  content  are  known  to  possess  strong
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antioxidant  properties60.  The  observed  antioxidant  activity  may  be  due  to  the  high
phenolic content of the extract. Hepato cellular necrosis leads to high levels of ASAT and
ALAT, which are released from liver into the blood. ALP activity, on the other hand, is
related  to  the  functioning  of  hepatocytes.  Increase  in  its  activity  is  due  to  increased
synthesis in the presence of increased biliary pressure61. Reduction in the levels of these
towards  the  respective  normal  values  in  liver  and  kidney  tissues  is  an  indication  of
stabilization of plasma membrane as well as repair of hepatic tissue damage caused by
tumor inoculation.
Lipid peroxidation refers to the oxidative degradation of lipids. It is the process
whereby free radicals "steal" electrons from the lipids in cell membranes, resulting in cell
damage. This process proceeds by a free radical chain reaction mechanism. It most often
affects  polyunsaturated  fatty  acids,  because  they  contain  multiple  double  bonds  in
between which lies methylene -CH2- groups that possess especially reactive hydrogen’s. 
Liver damage leads to the accumulation of fat and necrosis in the centrilobular
region of the liver. As a consequence,  the microsomal enzyme activities are found to
decrease and due to lipid peroxidation, the water soluble enzymes leak into plasma from
the liver. It is shown by the significant decrease in triglycerides and proteins in the liver
and kidney of the tumorinoculated animals62.  These changed parameters were restored
towards  the  normal  levels  by  leaves  of  cassia  fistula  linn  treatment,  indicating  its
hepatoprotective  nature.  The decreased bilirubin level  brought  about by the leaves of
Cassia fistula linn treatment indicates the normal functional conditions of the liver.
 It was observed that tumor cells produced more peroxides when they proliferate
actively after inoculation of tumor.  This rise in peroxides indicated the occurrence of
intensification  of  oxygen  free  radical  production62.  Cells  which  are  equipped  with
enzymatic  antioxidant  mechanisms  play  an  important  role  in  the  elimination  of  free
radicals.  High  levels  (up  to  0.05  µmol/h  per  104  cells)  of  H2O2  are  constitutively
released from a wide variety of human tumors  64.  SOD and CAT are involved in the
clearance of superoxide and H2O2. 
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Decrease in SOD and CAT activities described in tumors is regarded as markers
of  malignant  transformation.  Lowered  activities  of  SOD and  CAT  were  reported  in
several  cancers65.  The significant  elevation of SOD and CAT by the extract treatment
confirms the potent antioxidant activity of the leaves of Cassia fistula linn The elevation
of lipid peroxidation is known to be associated with cancer. MDA, the end product of
lipid peroxidation, was reported to be higher in cancer tissue than in normal tissues  66.
TBARS levels in the blood and the tested tissues in tumor control animals were found to
be higher than those in normal animals. The leaves of Cassia fistula linn treatment caused
a  significant  reduction in  TBARS levels  in  all  the samples  tested.  This  indicates  the
reduction in free radical yield and subsequent decrease in harm and damage to the cell
membrane and decrease in MDA production.
 The histological examination of the liver and kidney of DAL-inoculated animals
showed marked  changes  indicating the toxic effects  of  this  tumor.  Leaves  of  Cassia
fistula  linn may  cause  firstly  an  antitumor  effect  and  then  influence  biochemical
parameters.  Plant-derived  extracts  containing  antioxidant  principles  with  cytotoxicity
towards  tumor  cells  and antitumor  activity  in  experimental  animals  were  reported  67.
Plants  with  potent  antitumor,  hepatoprotective,  and  antioxidant  properties  were  also
reported 68.
6. CONCLUSION
The  present  investigation  was  carried  out  in  methanolic  extracts  of  leaves  of
Cassia  fistula  linn increased  the  life  span  of  Dal  tumor  bearing  mice  and  improve
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hematological  and antioxidant status and decreased the lipid peroxidation and thereby
enhance  the  endogenous  antioxidant  enzymes  in  the  liver.  The  biochemical  and
histological studies supported its anti tumor and antioxidant properties of   methanolic
extracts of leaves of Cassia fistula linn.
Further studies to characterize the active principle and elucidate the mechanism of
action of methanolic extracts of  leaves of Cassia fistula linn.
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